NZ615910B2 - Vascular characterization using ultrasound imaging - Google Patents
Vascular characterization using ultrasound imaging Download PDFInfo
- Publication number
- NZ615910B2 NZ615910B2 NZ615910A NZ61591012A NZ615910B2 NZ 615910 B2 NZ615910 B2 NZ 615910B2 NZ 615910 A NZ615910 A NZ 615910A NZ 61591012 A NZ61591012 A NZ 61591012A NZ 615910 B2 NZ615910 B2 NZ 615910B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- pulse
- blood vessel
- vessel
- echo data
- region
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title claims abstract description 133
- 230000002792 vascular Effects 0.000 title claims abstract description 122
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 110
- 238000010192 crystallographic characterization Methods 0.000 title description 7
- 238000002592 echocardiography Methods 0.000 claims abstract description 192
- 210000004204 Blood Vessels Anatomy 0.000 claims abstract description 170
- 238000006073 displacement reaction Methods 0.000 claims abstract description 88
- 230000017531 blood circulation Effects 0.000 claims abstract description 55
- 238000005070 sampling Methods 0.000 claims abstract description 53
- 230000000004 hemodynamic Effects 0.000 claims abstract description 25
- 210000001519 tissues Anatomy 0.000 claims description 54
- 238000002560 therapeutic procedure Methods 0.000 claims description 52
- 210000004369 Blood Anatomy 0.000 claims description 36
- 239000008280 blood Substances 0.000 claims description 36
- 238000005259 measurement Methods 0.000 claims description 23
- 230000000737 periodic Effects 0.000 claims description 16
- 230000000875 corresponding Effects 0.000 claims description 12
- 230000005284 excitation Effects 0.000 claims description 11
- 230000000747 cardiac effect Effects 0.000 claims description 10
- 239000004568 cement Substances 0.000 claims description 9
- 241000283986 Lepus Species 0.000 claims description 6
- 230000001276 controlling effect Effects 0.000 claims description 4
- 230000002596 correlated Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 20
- 210000001715 Carotid Arteries Anatomy 0.000 description 17
- 238000001914 filtration Methods 0.000 description 17
- 239000012530 fluid Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 9
- 230000004044 response Effects 0.000 description 8
- 230000002104 routine Effects 0.000 description 8
- 238000005314 correlation function Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 210000001367 Arteries Anatomy 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000002632 lipids Chemical group 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 238000002679 ablation Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000001965 increased Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 201000001320 atherosclerosis Diseases 0.000 description 4
- 230000001427 coherent Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drugs Drugs 0.000 description 4
- 230000003028 elevating Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 238000010845 search algorithm Methods 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 230000003044 adaptive Effects 0.000 description 3
- 210000004027 cells Anatomy 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000000051 modifying Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 241000311499 Bos grunniens x Bos taurus Species 0.000 description 2
- 241000229754 Iva xanthiifolia Species 0.000 description 2
- 238000005311 autocorrelation function Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000271 cardiovascular Effects 0.000 description 2
- 238000007374 clinical diagnostic method Methods 0.000 description 2
- 238000002091 elastography Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002608 intravascular ultrasound Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002093 peripheral Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000007502 Anemia Diseases 0.000 description 1
- 210000001217 Buttocks Anatomy 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000008787 Cardiovascular Disease Diseases 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 210000003743 Erythrocytes Anatomy 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N Levofloxacin Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 210000003041 Ligaments Anatomy 0.000 description 1
- 210000003324 RBC Anatomy 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241001325280 Tricardia watsonii Species 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000879 anti-atherosclerotic Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000003143 atherosclerotic Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001143 conditioned Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001808 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002939 deleterious Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000001809 detectable Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000003292 diminished Effects 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229950008597 drug INN Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000002675 image-guided surgery Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 1
- 230000001743 silencing Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 200000000009 stenosis Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001360 synchronised Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/085—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating body or organic structures, e.g. tumours, calculi, blood vessels, nodules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0891—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/485—Diagnostic techniques involving measuring strain or elastic properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/486—Diagnostic techniques involving arbitrary m-mode
Abstract
imaging method and a system for vascular imaging are disclosed. The system comprises one or more ultrasound transducers and a processing apparatus. The one or more transducers are configured to deliver ultrasound energy to a vascular region resulting in pulse-echo data therefrom. The processing apparatus is configured to control the capture of pulse-echo data at a frame rate such that measured displacement of a vessel wall defining at least one portion of a blood vessel in the vascular region and measured average blood flow through the at least one portion of the blood vessel have a quasi-periodic profile over time to allow motion tracking of both the vessel wall and the blood flow simultaneously; generate strain and shear strain image data for the region in which the at least one portion of the vessel is located using speckle tracking. The speckle tracking comprises using multi-dimensional correlation of pulse-echo data of one or more speckle regions undergoing deformation in the region in which the at least one portion of a blood vessel is located and the multi-dimensional correlation comprises determining a cross-correlation peak for the sampled pulse-echo data based on phase and magnitude gradients ofthe cross-correlated pulse-echo data; and The processing apparatus is further configured to identify at least one vascular characteristic of the vascular region in which at least one portion of a blood vessel is located based on the strain and shear strain image data. The at least one vascular characteristic comprises at least one of a flow characteristic associated with flow through the blood vessel, a structural characteristic associated with the blood vessel, and a hemodynamic characteristic associated with the blood vessel g apparatus is configured to control the capture of pulse-echo data at a frame rate such that measured displacement of a vessel wall defining at least one portion of a blood vessel in the vascular region and measured average blood flow through the at least one portion of the blood vessel have a quasi-periodic profile over time to allow motion tracking of both the vessel wall and the blood flow simultaneously; generate strain and shear strain image data for the region in which the at least one portion of the vessel is located using speckle tracking. The speckle tracking comprises using multi-dimensional correlation of pulse-echo data of one or more speckle regions undergoing deformation in the region in which the at least one portion of a blood vessel is located and the multi-dimensional correlation comprises determining a cross-correlation peak for the sampled pulse-echo data based on phase and magnitude gradients ofthe cross-correlated pulse-echo data; and The processing apparatus is further configured to identify at least one vascular characteristic of the vascular region in which at least one portion of a blood vessel is located based on the strain and shear strain image data. The at least one vascular characteristic comprises at least one of a flow characteristic associated with flow through the blood vessel, a structural characteristic associated with the blood vessel, and a hemodynamic characteristic associated with the blood vessel
Description
PCT/U52012/033584
VASCULAR CHARACTERIZATION USING ULTRASOUND IMAGlNG
ENT REGARDING FEDERALLY SPONSORED RESEARCH OR
DEVELOPMENT
{01] This invention was made with government support under award number EB 6893
from NIH. The government has n rights in this invention.
CROSS NCE TO RELATED APPLICATIONS
This application claims the benefit ofUS Provisional Application Serial No.
61/475,550, filed 14 April 2011, entitled “Vascular Characterization Using ound
Imaging,” which is incorporated herein by reference in its entirety.
BACKGROUND
The disclosure herein relates generally to ultrasound imaging. More particularly,
the disclosure herein pertains to ultrasound imaging methods and systems for use in, e.g.,
diagnostic and/or therapy ations (e.g., imaging ofblood vessels and/or s
proximate thereto, etc).
ar imaging is gaining sed attention not only as a way to detect
cardiovascular diseases, but also for the evaluation of response to new anti-
atherosclerotic therapies (see, Ainsworth, et 31., “3D ultrasound measurement of change
in carotid plaque volume — A tool for rapid evaluation ofnew therapies,” Stroke, vol. 36,
no. 9, pp. l904~1909, SEP 2005). Intravascular ultrasound (IVUS) has been shown to
provide an effective tool in measuring the progression or regression ofatherosclerotic
disease in response to therapies. However, IVUS is invasive, potentially risky, and more
expensive than noninvasive g with ultrasound.
PCT/U52012/033584
Advanced imaging modes on ultrasound scanners have led to increased interest in
imaging important quantities like wall shear rate (WSR) using Doppler (see, Blake, et
al., “A method to estimate wall shear rate with a clinical ultrasound scanner,”
Ultrasound in ne and y, vol. 34, no. 5, pp. 760-764, MAY 2008) and
tissue/wall motion (see, Tsou et al., “Role ofultrasonic shear rate estimation errors in
assessing inflammatory response and ar risk,” Ultrasound in Medicine and
Biology, vol. 34, no. 6, pp. 963~972, JUN 2008; Karimi et al., “Estimation ofNonlinear
. Mechanical Properties ofVascular Tissues via Elastography,” Cardiovascular
Engineering, vol. 8, no. 4, pp. 191-202, DEC 2008; and Weitzel, et al., “High-
tion Ultrasound Elasticity Imaging to Evaluate is Fistula Stenosis,”
Seminars In Dialysis, vol. 22, no. 1, pp. 84-89, JAN—FEB 2009) using speckle tracking.
Recently, there has been increased interest in imaging flow in conjunction with
computational fluid dynamic (CFD) modeling the tion of large artery
hemodynamics (see, Steinman et al., “Flow imaging and computing: Large artery
hemodynamics,” ANNALS OF BIOMEDICAL ENGINEERING, vol. 33, no. 12, pp.
1704—1709, DEC 2005; oa, et al., “A computational framework for fluid—solid-
growth modeling in cardiovascular tions,” Computer Methods in Applied
Mechanics and Engineering, vol. 198, no. 45- 46, pp. 3583 — 3602, 2009; and Taylor et
al., “Open problems in computational vascular biomechanics: Hemodynamics and
arterial wall mechanics,” Computer Methods in Applied Mechanics and Engineering,
vol. 198, no. 45—46, pp. 3514 — 3523, 2009). In this t, modeling fluid-solid
interfaces has been defined as a challenge area in vascular mechanics.
SUMIVIARY
At least one embodiment ofthis disclosure relates to ultrasound g capable of
simultaneously imaging both wall tissue motion (e.g., perivascular tissue) and
deformation, together with fluid flow. For example, in one ment ofthis
disclosure, imaging vascular mechanics using ultrasound is lished utilizing
speckle tracking (e.g., a 2D phase coupled speckle tracking method suitable for
subsample displacement estimation in both axial and lateral directions with minimum
interpolation) in conjunction with an imaging mode (e.g., M2D mode g) that
provides sufficient frame rates for vector displacement tracking in both tissue and fluid
PCT/U52012/033584
simultaneously. For example, MZD imaging may be implemented on a clinical scanner
equipped with a research interface for controlling the imaging sequence and streamlining
the RF data for performing 2D speckle tracking in a region of interest (e.g., around a
blood vessel). Combining 2D speckle tracking with sufficiently high frame rate imaging
allows for fine displacement tracking in both lateral and axial directions. Vector
displacement fields resulting from such processing are well suited for strain and shear
strain calculations with minimum filtering and using relatively small ng s
(i.e., speckle s) to maximize resolution. Flow and tissue motion strain fields (e.g.,
in a tissue/flow application, such as in vivo in the carotid of a patient) may be evaluated
(e.g., to identify vascular characteristics or for one or more other es, e.g., for use
in therapy).
One exemplary embodiment of an imaging method may include providing
ultrasound pulse—echo data of a region in which at least one portion of a blood vessel is
located (e.g., wherein the pulse—echo data comprises pulse-echo data at a frame rate such
that measured displacement of the vessel wall defining the at least one portion ofthe
blood vessel and measured average blood flow through the at least one portion ofthe
blood vessel have a quasi—periodic profile over time to allow motion tracking of both the
vessel wall and the blood flow aneously) and generating strain and shear strain
image data for the region in which the at least one portion of the vessel is located using
e tracking. For example, the speckle tracking may e using multi—
dimensional correlation ofpulse—echo data of one or more speckle regions undergoing
deformation in the region in which the at least one portion of a blood vessel is located
(e.g., wherein the multi—dimensional correlation ses determining a cross—
correlation peak for the sampled pulse—echo data based on phase and magnitude
nts of the cross-correlated pulse-echo data). Further, the method may e
fying at least one vascular characteristic ofthe region in which at least one portion
of a blood vessel is located based on the strain and shear strain image data (e.g., wherein
the at least one vascular characteristic comprises at least one of a flow characteristic
associated with flow through the blood , a structural characteristic ated with
the blood vessel, and a hemodynamic characteristic associated with the blood vessel).
Another exemplary imaging method may include providing ultrasound pulse—echo
data of a region in which at least one portion of a blood vessel is located and using
PCT/U52012/033584
speckle tracking of one or more speckle regions ofthe region in which at least one
portion ofthe blood vessel is located to track motion of both the vessel wall defining the
at least one portion ofthe blood vessel and the blood flow through the at least one
portion ofthe blood vessel. The pulse—echo data is provided at a frame rate such that
displacement of the vessel wall defining the at least one n of the blood vessel and
blood flow through the at least one portion ofthe blood vessel are measurable
simultaneously within a same periodic cycle (e.g., corresponding to a cardiac pulse
cycle). r, the method may include identifying at least one vascular characteristic
ofthe region in which at least one portion of a blood vessel is located based on the
simultaneously ed displacement ofthe vessel wall and average blood flow. Such
an imaging method may also include generating strain and shear strain image data for the
region in which the at least one portion ofthe vessel is located using the speckle
tracking, wherein the speckle tracking comprises using multi—dimensional ation of
sampled echo data of the one or more speckle regions undergoing deformation in
the region in which the at least one portion of a blood vessel is located (e.g., the multi—
dimensional correlation may include determining a cross-correlation peak for the
sampled pulse-echo data based on phase and magnitude gradients ofthe cross—correlated
d pulse-echo data).
In one or more embodiments of methods bed , identifying at least one
vascular characteristic may include identifying one or more vessel wall ries; and
still speckle tracking of such methods may include modifying a characteristic of at least
one ofthe one or more e s being tracked (e.g., location, size, shape, etc.)
based on the one or more vessel wall boundaries identified such that the at least one
speckle region is entirely within or outside ofthe vessel wall.
Further, in one or more embodiments of methods described herein, identifying at
least one vascular characteristic may include identifying vessel wall boundaries around
the entire blood vessel (e.g., wall boundaries in the entire cross—section view taken along
the axis of the vessel); may include measuring tissue property within the one or more
vessel wall boundaries (e.g., ess or compliance); may include identifying one or
more portions of a plaque architecture adjacent the one or more vessel wall boundaries
(e.g., such that therapy may be focused on a portion of such a structure; such as the base
thereof); and/or may include ating one or more hemodynamic measurements based
PCT/U52012/033584
on both the motion tracking motion ofthe vessel wall and the blood flow
aneously.
Still timber, in one or more embodiments of methods described herein, using
multi-dimensional correlation of d pulse-echo data of one or more speckle regions
may e using two~dimensional correlation of sampled pulse—echo data of one or
more speckle regions (tag, to track wall displacement or blood flow), and even three-
dimensional ation.
Yet further, in one or more embodiments of methods described herein, the method
may fiarther include delivering therapy to a patient based on the identification of the at
least one vascular characteristic of the region in which at least one portion of a blood
vessel is located (e.g., using ultrasonic energy to deliver y based on the
identification ofthe at least one vascular characteristic of the region in which at least one
portion of a blood vessel is located). For example, at least one transducer configured to
transmit and receive ultrasonic energy may be provided, wherein the at least one
ucer is used to obtain the pulse—echo data (e.g., for image data generation) and to
generate ultrasonic energy to deliver therapy.
In one or more other ments of methods described herein, generating strain
and shear strain image data for the region in which the at least one portion of the vessel
is located using two~dimensional speckle tracking may include generating at least one of
axial strain and axial shear strain image data and/or lateral strain and lateral shear strain
image data. Further, in such methods, ing ultrasound pulse-echo data of a region
in which at least one portion of a blood vessel is located may include using coded
excitation.
In yet one or more other embodiments of methods described herein, the method
may include applying a dereverberation filter to the pulse—echo data from one or more
speckle s in the blood to remove echo ents in the pulse—echo data due to
reflection at the vessel wall when performing speckle tracking ofthe pulse-echo data
from the one or more speckle regions in the blood.
PCT/U52012/033584
Another exemplary imaging method may include providing ultrasound pulse~echo
data of a region in which at least one portion of a blood vessel is located; using e
tracking of one or more speckle regions ofthe region in which the at least one portion of
the blood vessel is d to track motion of at least one of the vessel wall defining the
at least one portion of the blood vessel and the blood flow through the at least one
portion ofthe blood vessel; identifying one or more vessel wall boundaries based on the
speckle tracking of the one or more speckle regions; and modifying at least one
characteristic of at least one of the one or more speckle regions being tracked based on
the one or more vessel wall boundaries identified such that the at least one speckle
region is entirely within or e ofthe vessel wall (e.g., the at least one of the one or
more speckle s being tracked may be modified by at least one of location, size, or
shape based on the one or more vessel wall boundaries fied such that the at least
one speckle region is entirely within or outside ofthe vessel wall).
In another exemplary imaging method, the method may include ing
ultrasound pulse-echo data of a region in which at least one portion of a blood vessel is
located; using speckle tracking of one or more speckle regions ofthe region in which at
least one portion of the blood vessel is d to track motion of at least blood flow
through the at least one portion ofthe blood vessel; and removing echo ents in
the pulse—echo data due to reflection at the vessel wall when performing speckle tracking
ofthe pulse-echo data from the one or more speckle regions in the blood (e.g., ng
echo components in the pulse—echo data due to reflection at the vessel wall may include
using a time—varying inverse filter to reduce the components in the pulse—echo data due
to reflection at the vessel wall).
One exemplary embodiment of a system for vascular imaging may include one or
more ultrasound transducers (e.g., wherein the one or more transducers are red to
deliver ultrasound energy to a vascular region resulting in pulse—echo data therefrom)
and processing apparatus red (e.g., operative by execution of one programs,
routines, or instructions to cause the performance of one or more functions) to control
the capture of pulse—echo data at a frame rate such that measured displacement of a
vessel wall defining at least one portion of a blood vessel in the vascular region and
measured average blood flow through the at least one portion ofthe blood vessel have a
quasi—periodic profile over time to allow motion tracking of both the vessel wall and the
2012/033584
blood flow simultaneously; to generate strain and shear strain image data for the region
in which the at least one portion of the vessel is located using speckle tracking (e.g.,
wherein the speckle tracking may e using multi—dimensional correlation of pulse-
echo data of one or more speckle regions undergoing deformation in the region in which
the at least one portion of a blood vessel is located; the multi-dimensional correlation
may include determining a cross—correlation peak for the d pulse—echo data based
on phase and magnitude gradients ofthe cross—correlated pulse—echo data); and to
identify at least one vascular teristic ofthe vascular region in which at least one
portion of a blood vessel is located based on the strain and shear strain image data (e.g.,
wherein the at least one vascular teristic comprises at least one of a flow
characteristic associated with flow through the blood vessel, a structural characteristic
associated with the blood vessel, and a hemodynamic characteristic associated with the
blood vessel).
Another exemplary system for vascular imaging may include one or more
ultrasound transducers (e.g., wherein the one or more transducers are configured to
deliver ultrasound energy to a vascular region resulting in pulse—echo data therefiom)
and processing apparatus red (cg, operative by execution of one programs,
routines, or instructions to cause the performance of one or more functions) to control
the capture of pulse-echo data of the vascular region in which at least one portion of a
blood vessel is located and use speckle tracking of one or more e regions of the
vascular region in which at least one portion ofthe blood vessel is located to track
motion ofboth the vessel wall defining the at least one portion ofthe blood vessel and
the blood flow through the at least one portion of the blood . The pulse-echo data
may be captured at a frame rate such that displacement ofthe vessel wall defining the at
least one portion ofthe blood vessel and blood flow through the at least one portion of
the blood vessel are measurable simultaneously within a same periodic cycle
corresponding to a cardiac pulse cycle. Further, the processing tus may be
configured to identify at least one vascular characteristic ofthe vascular region in which
the at least one portion ofthe blood vessel is located based on the simultaneously
measured displacement of the vessel wall and average blood flow. In one embodiment
of such a system, the processing apparatus may further be operable to te strain and
shear strain image data for the region in which the at least one portion of the vessel is
located using the e tracking (e.g., wherein the e tracking may include using
PCT/U52012/033584
multi—dimensional correlation of sampled pulse—echo data ofthe one or more speckle
regions undergoing deformation in the region in which the at least one portion of a blood
vessel is located; and further wherein the multi-dimensional correlation may include
ining a cross—correlation peak for the d pulse—echo data based on phase and
magnitude gradients ofthe cross-correlated sampled pulse-echo data).
In one or more ments ofthe exemplary systems provided herein, the
processing apparatus may be operable to identify one or more vessel wall ries,
and still further, the processing apparatus may be operable, when using the speckle
tracking, to modify a characteristic of at least one of the one or more speckle regions
being tracked (e.g., the location, size, shape, etc.) based on the one or more vessel wall
boundaries identified such that the at least one speckle region is ly within or
outside ofthe vessel wall.
Further, in one or more embodiments of the exemplary systems, the processing
apparatus may be le to fy vessel wall boundaries around the entire blood
vessel; the processing apparatus may be operable to e tissue property within the
one or more vessel wall boundaries; the processing apparatus may be operable to identify
one or more portions of a plaque architecture nt the one or more vessel wall
ries; and/or the processing tus may be operable to calculate one or more
hemodynamic measurements based on both the motion tracking motion ofthe vessel
wall and the blood flow simultaneously.
Still further, in one or more embodiments of the exemplary systems provided
, the processing apparatus may be operable to use two-dimensional correlation of
sampled pulse-echo data of one or more speckle regions (e.g., to track speckle regions),
and even three~dimensional correlation.
Yet timber, in one or more embodiments ofthe exemplary systems provided
herein, the system may further include a therapy apparatus to deliver therapy to a patient
based on the identification of the at least one vascular characteristic ofthe region in
which at least one portion ofa blood vessel is located (e.g., a device operable to use
ultrasonic energy to deliver therapy based on the identification ofthe at least one
vascular characteristic of the region in which at least one portion of a blood vessel is
PCT/U52012/033584
located). For example, the therapy tus may include at least one transducer
configured to transmit and receive ultrasonic energy, wherein the at least one transducer
is operable to e ultrasonic energy to deliver y based on the fication of
the at least one vascular characteristic of the region in which at least one portion of a
blood vessel is located and the at least one transducer is operable for use in obtaining the
pulse~echo data to generate image data.
Still r, in one or more embodiments of the exemplary systems provided
herein, the processing apparatus may be operable to te strain and shear strain
image data for the region in which the at least one portion of the vessel is located using
mensional speckle tracking, wherein using mensional speckle tracking
comprises generating at least one of axial strain and axial shear strain image data and/or
lateral strain and lateral shear strain image data. Further, for example, the processing
apparatus may be operable to control providing ultrasound pulse-echo data of a region in
which at least one n of a blood vessel is located using coded excitation.
Still r, in another ofthe one or more embodiments of the exemplary systems
provided herein, the processing tus may be operable to apply a dereverberation
filter to the pulse—echo data from one or more speckle regions in the blood to remove
echo components in the pulse—echo data due to reflection at the vessel wall when
performing speckle tracking of the pulse—echo data from the one or more speckle regions
in the blood.
Another exemplary system for vascular imaging may include one or more
ound transducers (eg, wherein the one or more transducers are configured to
deliver ultrasound energy to a vascular region resulting in pulse—echo data therefrom)
and processing apparatus configured to control capture of ultrasound pulse—echo data of
the vascular region in which at least one portion of a blood vessel is located; use speckle
tracking of one or more e regions ofthe vascular region in which the at least one
portion ofthe blood vessel is located to track motion of at least one ofthe vessel wall
defining the at least one portion of the blood vessel and the blood flow through the at
least one portion of the blood vessel; identify one or more vessel wall boundaries based
on the speckle tracking ofthe one or more speckle regions; and modify a characteristic of
at least one of the one or more speckle regions being tracked based on the one or more
PCT/U52012/033584
vessel wall boundaries identified such that the at least one speckle region is entirely
within or outside ofthe vessel wall. For example, the processing apparatus may be
operable to modify at least one of on, size, or shape of the at least one e
region based on the one or more vessel wall boundaries identified such that the at least
one speckle region is entirely within or outside ofthe vessel wall.
In yet another exemplary system for ar imaging, the system may include one
or more ound transducers (e.g., wherein the one or more transducers are configured
to deliver ultrasound energy to a vascular region resulting in pulse-echo data therefrom)
and processing apparatus red to control e of ultrasound pulse—echo data of
the vascular region in which at least one portion of a blood vessel is located; use speckle
tracking of one or more speckle regions of the region in which at least one n of the
blood vessel is located to track motion of at least blood flow through the at least one
portion ofthe blood vessel; and remove echo components in the pulse-echo data due to
reflection at the vessel wall when performing e tracking of the pulse-echo data
fiom the one or more speckle regions in the blood (e.g., using a time—varying inverse
filter to reduce the components in the pulse—echo data due to reflection at the vessel
wall).
Still further, another exemplary system for vascular imaging may include one or
more ultrasound transducers (e.g., wherein the one or more transducers are configured to
deliver ultrasound energy to a vascular region resulting in pulse-echo data therefrom);
apparatus for controlling the capture of pulse—echo data at a frame rate such that
measured displacement of a vessel wall defining at least one portion of a blood vessel in
the vascular region and measured average blood flow through the at least one n of
the blood vessel have a quasi—periodic profile over time to allow motion tracking of both
the vessel wall and the blood flow simultaneously; apparatus for generating strain and
shear strain image data for the region in which the at least one portion ofthe vessel is
located using speckle tracking (e.g., wherein the speckle tracking may include using
inulti-dimensional ation of pulse—echo data of one or more e regions
undergoing deformation in the region in which the at least one n of a blood vessel
is located, and further wherein the multi—dimensional correlation may include
determining a cross—correlation peak for the d pulse—echo data based on phase and
magnitude gradients of the cross—correlated pulse—echo data); and apparatus for
-10..
PCT/U52012/033584
identifying at least one vascular characteristic ofthe vascular region in which at least one
portion of a blood vessel is located based on the strain and shear strain image data (e.g.,
wherein the at least one vascular characteristic comprises at least one of a flow
characteristic associated with flow through the blood vessel, a structural characteristic
associated with the blood vessel, and a hemodynamic characteristic associated with the
blood vessel). Further, for example, the system may include therapy apparatus for
delivering therapy to a patient based on the identification ofthe at least one vascular
characteristic of the region in which at least one portion of a blood vessel is d (e.g.,
ultrasound therapy tus).
AThe above summary is not ed to describe each embodiment or every
implementation of the present disclosure. A more complete understanding will become
apparent and appreciated by referring to the following detailed description and claims
taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
is a block diagram depicting an exemplary ultrasound imaging , with
an optional therapy .
I31] is a flow chart depicting an exemplary ultrasound imaging method.
is a block diagram of one exemplary embodiment ofan g system
shown generally in Figure 1.
is a block m of one ary GPU implementation of an imaging
system such as shown in Figure 3.
FIG. SA-SD provides exemplary graphs showing channel diameter and average
flow velocity over time for image data captured at various frame rates.
FIGS. 6A—6B shown graphs including contours of certain parameters of cross—
correlations used to describe one exemplary embodiment of speckle ng that may be
used in an imaging method and/or system shown generally in Figures 1-2.
PCT/U52012/033584
provides an exemplary image of a blood vessel for use in describing one or
more methods and/or systems shown generally in s 1—2 as they relate to vascular
diagnostics or vascular therapy.
FIGS. 8A-SB show axial stain and axial shear strain images of flow channel walls
ng to examples carried out and bed at least in part herein.
FIGS. 9A—9B show l stain and lateral shear strain images offlow channel
walls relating to examples carried out and described at least in part herein.
shows a graph of channel diameter computed from tracked channel wall
displacements over time and average flow velocity obtained from tracked fluid
displacements over time Within a flow channel relating to an example carried out and
described at least in part herein.
shows graphs oftotal displacement vector waveforms with a channel at
ent time ces relating to an example carried out and described at least in part
herein.
FIGS. B show axial stain and axial shear strain images of carotid artery
longitudinal vessel walls relating to examples carried out and described at least in part
herein.
FIGS. l3A-13B show lateral stain and lateral shear strain images of carotid artery
longitudinal vessel walls relating to examples carried out and described at least in part
FIGS. 14A-14B Show axial stain and axial shear strain images of d artery
cross-sectional vessel walls relating to examples carried out and described at least in part
herein.
FIGS. ISA—15B show lateral stain and lateral shear strain images of carotid artery
cross~sectional vessel walls relating to examples carried out and described at least in part
herein.
PCT/U52012/033584
FIGS. 16A-l 6B show lateral and axial displacements relating to dereverberation
filtering examples.
[46} FIGS. 17A—l7B show spatio—temporal maps relating to dereverberation filtering
examples.
I47] FIGS. B show spatio—temporal maps relating to dereverberation filtering
FIGS. 19A—19D show graphs relating to dereverberation filtering results of
examples presented herein.
DETAILED PTION OF EXEMPLARY EMBODIMENTS
I49] In the following detailed description of illustrative embodiments, reference is made
to the accompanying figures ofthe drawing which form a part hereof, and in which are
shown, by way of illustration, specific embodiments which may be practiced. It is to be
understood that other embodiments may be utilized and structural changes may be made
without departing from (e.g., still falling within) the scope ofthe disclosure presented
hereby.
Exemplary methods, apparatus, and systems shall be described with reference to
Figures 1—19. It will be apparent to one skilled in the art that elements or processes (e.g.,
ing steps thereof) from one embodiment may be used in combination with
ts or processes ofthe other embodiments, and that the le embodiments of
such methods, apparatus, and systems using combinations of features set forth herein is
not limited to the specific embodiments shown in the Figures and/or bed herein.
Further, it will be recognized that the embodiments described herein may include many
elements that are not necessarily shown to scale. Still fiirther, it will be recognized that
timing ofthe processes and the size and shape of various elements herein may be
d but still fall within the scope of the present disclosure, although certain
timings, one or more shapes and/or sizes, or types of elements, may be ageous
over others.
PCT/U52012/033584
shows an exemplary ultrasound imaging system 10 including processing
apparatus (block 12) and one or more ultrasound transducers, such as a transducer array
that provides for transmission of pulses and reception of echoes (block 22). The
sing apparatus (block 12) may be operably coupled to the one or more transducers
(block 22) to facilitate imaging ofan object of interest (e.g., capture of pulse-echo data)
using the one or more transducers (block 22). Further, the sing tus (block
12) includes data storage (block 14). Data storage (block 14) allows for access to
sing programs or routines (block 16) and one or more other types of data (block
18) that may be employed to carry out the exemplary g methods (e.g., one which
is shown generally in the block diagram of.
For example, processing programs or routines (block 16) may include programs or
routines for performing computational mathematics, matrix mathematics, compression
thms (e.g., data compression algorithms), calibration algorithms, image
construction algorithms, inversion algorithms, signal processing algorithms,
rdization algorithms, comparison thms, vector mathematics, or any other
processing required to implement one or more embodiments as described herein (e.g.,
provide imaging, carry out speckle tracking, generate strain images, etc). ary
mathematical formulations/equations that may be used in the systems and methods
described herein are more specifically described herein with reference to FIGS. 3—19.
Data (block 18) may include, for example, sampled pulse—echo information (e.g.,
sampled or collected using the one or more transducers (block 22)), data representative
ofmeasurements (e.g., vascular characteristics), results from one or more processing
programs or routines employed according to the disclosure herein (e.g., reconstructed
strain images of an object of interest, such as a blood vessel or regions around same), or
any other data that may be ary for carrying out the one or more processes or
methods bed herein.
In one or more embodiments, the system 10 may be implemented using one or
more computer programs executed on programmable ers, such as computers that
include, for example, processing capabilities (e.g., er processing units (CPUS),
graphical processing units (GPUs)), data storage (e.g., volatile or latile memory
and/or storage elements), input devices, and output devices. Program code and/or logic
-14_
PCT/U52012/033584
described herein may be applied to input data to perform functionality described herein
and generate desired output ation (e.g., strain images, vascular characteristics,
etc.). The output information may be applied, or otherwise used, as input to, or by, one
or more other devices and/or processes as described herein (e.g., one or more therapy
tus (block 20) such as a drug therapy apparatus, an ultrasound therapy apparatus,
etc.).
The program(s) or routine(s) used to ent the ses described herein may
be provided using any programmable language, e.g., a high level procedural and/or
object orientated programming language that is suitable for communicating with a
computer system. Any such programs may, for example, be stored on any suitable
device, e.g., a storage media, readable by a general or special purpose program, computer
or a processor apparatus for configuring and operating the er (e. g., processor(s))
when the suitable device is read for performing the procedures described herein. In other
words, at least in one embodiment, the system 10 may be implemented using a computer
readable storage medium, configured with a er m, where the storage
medium so configured causes the computer to operate in a specific and predefined
manner to perform functions described herein.
Likewise, the imaging system 10 may be configured at a remote site (e.g., an
application server) that allows access by one or more users via a remote computer
apparatus (e.g., via a web browser), and allows a user to employ the functionality
according to the present disclosure (e.g., user accesses a graphical user interface
associated with one or more programs to process data).
The processing tus (block 12), may be, for example, any fixed or mobile
computer system (e.g., a personal computer or minicomputer, for example, with a CPU,
GPU, etc.). The exact configuration ofthe ing apparatus is not ng and
essentially any device capable of providing le computing capabilities and l
capabilities (e.g., control the imaging set up configuration and acquire data, such as
pulse—echo data) may be used. Further, various peripheral devices, such as a computer
y, mouse, keyboard, , printer, scanner, etc. are contemplated to be used in
combination with the processing apparatus (block 12), such as for visualization of
2012/033584
imaging results (e.g., display of strain images, display oftherapy delivery in real time
such as with use of high intensity focused ultrasound, etc).
Further, in one or more embodiments, the output (e.g., an image, image data, an
image data file, a digital file, a file in user—readable format, etc.) may be ed by a
user, used by another machine that provides output based thereon, etc.
I59] As described herein, a digital file may be any medium (e.g., volatile or non—volatile
memory, a CD—ROM, a punch card, magnetic recordable tape, etc.) containing digital
bits (e.g., encoded in binary, trinary, etc.) that may be readable and/or writeable by
sing tus (block 14) described herein.
Also, as bed herein, a file in user—readable format may be any representation
of data (cg, ASCII text, binary numbers, hexadecimal numbers, decimal numbers,
audio, graphical) presentable on any medium (e.g., paper, a display, sound waves, etc.)
readable and/or understandable by a user.
[61l lly, the methods and systems as described herein may utilize algorithms
implementing computational mathematics (e.g., matrix. inversions, tutions, Fourier
transform techniques, etc.) to reconstruct the images described herein (e.g., from pulse-
echo data).
In View of the above, it will be readily apparent that the functionality as described
in one or more embodiments according to the present disclosure may be implemented in
any manner as would be known to one skilled in the art. As such, the computer
language, the computer system, or any other re/hardware which is to be used to
implement the processes described herein shall not be limiting on the scope of the
systems, processes or ms (e.g., the functionality provided by such systems,
processes or programs) described herein.
I63] One will recognize that a graphical user interface may be used in conjunction with
the embodiments described herein. The user ace may provide various features
allowing for user input thereto, change of input, importation or exportation of files, or
any other features that may be lly suitable for use with the processes described
—16—
PCT/U52012/033584
herein. For example, the user interface may allow default values to be used or may
require entry of certain values, , threshold , or other pertinent information.
The methods described in this disclosure, including those uted to the systems,
or various constituent components, may be implemented, at least in part, in hardware,
software, firmware, or any combination thereof. For example, various aspects ofthe
ques may be implemented within one or more processors, including one or more
microprocessors, DSPs, ASICS, FPGAs, or any other equivalent integrated or discrete
logic circuitry, as well as any ations of such components, image processing
s, or other devices. The term "processor" or "processing try" may generally
refer to any ofthe foregoing logic circuitry, alone or in combination with other logic
circuitry, or any other equivalent circuitry.
Such hardware, software, and/or e may be implemented within the same
device or within separate devices to support the various operations and functions
described in this disclosure. In addition, any of the described components may be
implemented together or separately as te but interoperable logic devices.
Depiction of different features, e.g., using block diagrams, etc., is intended to highlight
different functional s and does not necessarily imply that such features must be
realized by separate hardware or software components. Rather, functionality may be
performed by separate hardware or software ents, or integrated within common
or separate hardware or software components.
When implemented in software, the functionality ascribed to the s, devices
and methods described in this sure may be embodied as instructions on a
computer—readable medium such as RAM, ROM, NVRAM, EEPROM, FLASH
memory, magnetic data storage media, optical data storage media, or the like. The
instructions may be executed by one or more processors to support one or more aspects
ofthe fiinctionality described in this disclosure.
The imaging system 10 may further be used with, or may form a part of an optional
therapy apparatus (block 20). For example, the therapy tus (block 20) may use the
results of ultrasound imaging to provide one or more therapies. In one or more
embodiments, the therapy apparatus (block 20) may be a non-invasive or invasive
PCT/U52012/033584
therapy tus such as a drug delivery apparatus or system (delivery of a drug to a
particular location), a surgical apparatus or system (e.g., delivery of a stent to a particular
position), an ablation apparatus or system (e.g., a high frequency or high intensity
d ultrasound therapy apparatus or ), etc.
I68] In one or more embodiments, the therapy apparatus (block 20) may be a separate
system or apparatus that receives an output from the g system (e.g., image
information) and delivers one or more ies. In other embodiments, the y
apparatus (block 20) may be integrated with the imaging system to perform the one or
more therapies (e.g., a high intensity focused ultrasound system that uses dual mode
ultrasound transducer(s); for diagnostics such as imaging, as well as for treatment, such
as ablation). For example, in one or more embodiments, the therapy apparatus (block 20)
may include one or more portions of a system such as described in PCT International
Publication No. W02009/002492 entitled “Image Guided Plaque Ablation,” published
31 er 2008, and incorporated herein by reference. For example, the ound
imaging described herein may be used for ng vascular plaque non—invasively. For
example, the ultrasound imaging described herein may be used to identify flow and
vascular characteristics needed to non—invasively perform ablation of plaque as described
in PCT International Publication No. W02009/002492.
For example, the therapy system may be a system for non—invasively elevating the
temperature oftissue by ultrasound energy waves including: at least one ultrasound
delivery device adapted to deliver ultrasound energy waves to a focal point oftargeted
tissue; a ature monitoring device for monitoring the temperature oftargeted tissue
at the focal point; and a controller for steering and controlling the ultrasound delivery
device to deliver ound energy waves at a focal point to elevate the ature of
targeted tissue to a desired ature.
[701 Further, for example, the therapy system may use one or more imaging systems
described herein to produce an image of at least a portion of a mammalian body, e.g.,
such that the location of at least one vascular plaque in said image can be determined and
to ascertain the location ofthe base of said vascular plaque. For example, ultrasound
delivery device may ain one or more target locations at the base ofthe plaque. Still
further one or more embodiments of the imaging system provided herein may be used in
~18—
PCT/U52012/033584
a method for elevating the temperature at a target location by an energy wave using an
ultrasound therapy system (e.g., which may be the same ultrasound system (ultrasound
transducers thereof) used for imaging). For example, the method may include delivering
a beam of ultrasound energy waves from a source to the target location; monitoring the
temperature ofthe target location; and stopping the delivering of the beam ofultrasound
energy waves if a desired temperature at the target location has been reached.
Further, a method of preparing a plan for non—invasively elevating the ature
oftissue in a vessel wall leading to regression of ar plaques may include imaging
at least a portion of a body to produce an image (e.g., using ultrasound imaging as
described herein to image a vascular region); determining the location of at least one
ar plaque in said image; ascertaining the location of the base of said vascular
plaque and one or more target ons at the base ofthe plaque (e.g., using the
ound generated image); and/or determining the parameters for delivering
ound energy waves from a source to a focal point for elevating the ature of
targeted tissue in the vessel wall to a desired temperature, sufficient for reducing or
destroying vaso vasorum.
Further, for example, the ultrasound imaging described herein may be used to
fy flow and vascular characteristics needed to perform invasive treatments of
plaque (e.g., stent ry, c surgery, etc.)
Still further, in one or more embodiments, the therapy apparatus (block 20) may
include one or more portions of a system such as described in US Provisional Patent
Application No. 61/353,096, entitled “Dual Mode Ultrasound Transducer (DMUT)
System for Monitoring and Control of Lesion Formation Dynamics” filed 9 June 2010,
and which is incorporated by reference herein. For example, the ultrasound g
described herein may be performed with the same or similar transducer arrays described
therein which can be used for both imaging (e.g., to monitor a therapy procedure), as
well as for delivering y (e.g., to deliver high intensity focused ultrasound energy).
For example, therapy may be red using the ultrasound ucer array, while the
imaging modes using the same transducer array may be used to guide the therapeutic
beam, assess thermal and mechanical tissue response to estimate doses of therapy (e.g.,
initial dose oftherapy), monitor and characterize tissue response during therapy, and
PCT/U52012/033584
assess the state ofthe treated tissue at the completion of each re to the therapeutic
ound energy (e.g., real time monitoring n periods of therapy delivery).
For e, ultrasound imaging as described herein may be used to identify one
or more vascular teristics. An exemplary diagram of a blood vessel 50 is shown in
Figure 7 to facilitate discussion of the use of imaging described herein. The blood vessel
50 shown in Figure 7 includes a vessel wall 52 having a plaque structure 54 formed on
the interior of the vessel wall 52. The plaque architecture ofthe structure 54 may
include, for example, a plaque base 56, a lipid core 58, and a fibrous or calcified cap 60.
Blood 62 flows through the blood vessel 50 defined by the vessel wall 52.
One or more embodiments ofmethods and/or systems described herein may be
used to identify one or more vascular characteristics, e.g., flow characteristics associated
with the flow through the blood vessel 50, structural characteristics associated with the
blood vessel 50, and/or hemodynamic characteristics. For example, flow characteristics
may include flow velocity, volume flow, wall shear stress, wall shear rate, etc.
For e, structural characteristics may include determining boundaries of the
vessel wall (e.g., outer and inner boundaries, such as in a coordinate system), thickness
ofthe vessel wall, measurement oftissue properties within the vessel wall (e.g., stiffness
oftissue, such as, for example, it relates to a diseased state), differentiation of plaque
from vessel wall, differentiation ofthe s components of plaque (e.g.,
differentiation ofbase from lipid core, differentiation ofbase from fibrous cap,
differentiation of lipid core from fibrous cap, etc), etc. For example, in one or more
embodiments, upon differentiation ofthe base from the fibrous cap of the plaque
architecture, treatment may be provided to ablate the base to reduce filrther plaque
p or growth or provide treatment according to PCT International Publication No.
/002492.
Still further, for example, hemodynamic characteristics may include calculated
namic measurements, such as, for example, arterial pressure, cardiac output,
arterial compliance, pulse wave velocity, etc. At least in one embodiment, such
namic measurements may be determined based on parameters ng to both
tracking ofthe blood flow and tracking of vessel wall motion or displacement. As such,
PCT/U52012/033584
to obtain an accurate hemodynamic determination, the parameters or measurements
relating to both tracking of the blood flow and tracking of vessel wall motion or
displacement must be determined simultaneously, or within a periodic cycle in which
both can be determined (e.g., determined effectively). For example, compliance of the
vessel may be based on both volume flow which relates to tracking of blood flow and
re within the vessel which can be determined by tracking vessel displacement.
For example, accurate tion ofthe vessel diameter and estimation of the
l flow within the lumen with high frame rate imaging will allow for usefiil
measurement of the pulse wave velocity (PWV) noninvasively. For example, the time
waveforms shown in, for e, Figures SC—SD can be plotted in phase space (volume
flow, QA, vs. vessel area, A). Volume flow can be calculated from the flow data, while
the area can be obtained from the vessel wall movement. This measurement must be
made during the ion—free part ofthe heart cycle in the form of a slope
measurement of the form PWV=dQ/dA. With the adequately sampled time waveforms
(e.g., using MZD mode imaging), the task of estimating the vessel wall motion and the
flow within the vessel can be accomplished.
In other words, both lateral flow velocity and wall motion can be ted
aneously thus providing pressure (through vessel diameter) and flow (through
vector velocity)). Such measurements can provide the basis for namic
computations that may be used in the assessment of vessel wall compliance, an
important indicator of the health ofthe vessel as described herein. Further, as described
herein, axial and lateral displacement fields are ehaved and allow for strain and
shear strain calculations in both tissue and blood. Together with anatomical image
information, these velocity/strain fields may e input for computational fluid
dynamic models, which may allow for inverse calculations suitable for the assessment of
the health of the vasculature and nding tissue (e.g. detection and staging of
atherosclerosis).
In one or more embodiments, the ultrasound—enabled quantitative imaging system
may be used for assessment ofthe disease state in atherosclerotic blood vessels. For
example, the imaging may be used for the direct estimation of the strain fields in the
vicinity of the vessel walls. Such methods may mitigate the deleterious effects of local
PCT/U52012/033584
deformations that could result in loss ofcorrelation, and which may render the
ation—based speckle tracking approach useless in the Vicinity ofthe vessel wall.
Such deformations, depending on severity, could result in erroneous estimate in the
velocity (and therefore strain) estimation or may even result in loss of accuracy.
A three—pronged approach to the problem of restoring the true velocity/strain
estimates may include: 1) A ep algorithm for direct estimation ofthe
velocity/strain components using a deformed model of the 2D RF data in the vicinity of
the wall, 2) A tructive approach employing a forward computational fluid
dynamics (CFD) model as a regularization filter, and 3) A quantitative inverse
reconstruction ofthe tissue mechanical properties using ultrasound—based ty/strain
fields as observations. As described herein, simultaneous imaging of tissue motion and
flow with subsample accuracy in both axial and lateral directions may be implemented.
For e, such imaging may include using a phase—coupled 2D e tracking
approach, which employs the true 2D x cross correlation to find sub—pixel
displacements in both axial and lateral directions. Further, a modified imaging sequence
on a Sonix RP scanner to allow high fiame rate 2D data collection in a limited field of
View ng the region of interest (MZD-mode) may be used. Together with the robust
2D speckle tracking method, M2D imaging allows for capturing the full dynamics ofthe
flow and wall/tissue motion, even when the flow is primarily in the lateral direction
(with t to the imaging beam). The fine vector cement estimates in both axial
and lateral directions are shown to allow for smooth and contiguous strain and shear
strain calculations with minimal filtering. The simultaneous imaging of the vector flow
field and the wall/tissue motion and the corresponding strains at high spatial and
temporal sampling may provide a tool in ng the fluid—solid interactions between
the blood and blood vessel. Such an image-based modeling of the vessel response may
allow for the prediction of the disease state and possible ion of the disease state.
Furthermore, the ation n the observation model and inverse
reconstruction ofthe tissue properties in the vicinity ofthe vessel wall may allow for
quantitative assessment of the plaque composition (e.g. lipid content or calcification).
This may provide a reliable noninvasive model for selecting treatment options based on
probability ofrupture and other risk factors.
PCT/U52012/033584
In other words, the imaging bed herein may be used in conjunction with
computational fluid dynamic (CFD) modeling the evaluation of large artery
hemodynamics. CFD has been shown to produce useful prediction oftime—varying, 3D
flow fields in large arteries with complex geometries. In this context, modeling fluid-
solid interfaces has been defined as a nge area in vascular mechanics. Imaging
methods as described herein capable of capturing both perivascular (and wall) tissue
motion and deformations, together with fluid flow may be used to s this issue.
Advances in MRI and other imaging modalities have led to increased interest in image—
based, patient—specific CFD modeling to monitor disease progression. MRI has
excellent soft tissue contrast that may allow the accurate capture of the tissue (solid)
model. Although this may be an advantage over diagnostic ound, which does not
offer the same level of definition for tissue boundaries and discrimination between tissue
types, this tion may be mitigated, however, by the recent improvements in 3D
image acquisition, both freehand and zed. Therefore, diagnostic ultrasound
scanners may provide an attractive alternative for image-based CFD modeling. Based on
3D ultrasound and improved 2D velocity/strain imaging using MZD mode, processes for
providing quantitative tissue property images in the vicinity of the vessel wall for the
characterization ofthe e state may be ented. The imaging s
described herein address the limitations of existing correlation—based s for
velocity/strain estimation to restore the lost or artifact—ridden tes in the vicinity of
the wall. Further, the integration of our velocity/strain estimation as an ation
model in a dynamic, forward/inverse CFD—based model for the reconstruction ofthe
field/tissue property values consistent with the -Stokes equations may be
accomplished. For example, the following may be developed: a two—step algorithm for
direct strain estimation at the vessel wall using MZD—mode data; a regularized approach
for the reconstruction of displacement/strain maps utilizing a d CFD model
obtained from 3D Ultrasound (e.g., the forward model may provide a reconstruction
filter to regularize the velocity/strain estimation obtained using the speckle tracking
algorithm); and/or an inverse method for the reconstruction ofthe mechanical properties
in the Vicinity of the vessel wall based on strain maps obtained using de data.
The one or more ultrasound transducers (block 22) may be any apparatus (e.g.,
transmitting, receiving components, etc.) capable of delivering ultrasound pulses and
PCT/U52012/033584
sampling/collecting ultrasound echo energy contemplated to be used in ound
imaging systems and in combination with processing apparatus (block 12) of the system
. As used herein, such transducers may include a transmitting portion, e.g., to deliver
pulse energy, and a receiving portion, e.g., to sample/collect echo or reflected energy,
which may or may not be the same n. During the ultrasound imaging of a target
(e.g., a blood vessel, such as a carotid artery, coronary artery, etc.), the one or more
transducers (block 22) may be positioned relative to the target so as to be capable of
delivering energy to the target resulting in reflected energy (also known as the resultant
pulse—echo or echo energy) and also sampling the echo .
The one or more ucers (block 22) may include multiple transducers position
separately from one another or may be a transducer array. In one or more embodiments,
various arrays may have one or more benefits over others. For example, in one or more
embodiments, the transducer array may be a segmented concave transducer with multiple
sub—apertures to insonify the vessel from multiple angles. This will allow for better
definition of the vessel boundaries from more directions. At least one sub—aperture may
be used in linear array or phased array mode for initial B-mode and strain imaging of the
vessel. The driver of the ucer may be designed to drive the multiple sub—apertures
with independent codes. Each sub-aperture may be a one-dimensional or two—
dimensional array. Coded excitation may help improve both the data rates (e.g., provide
higher frame rates) and echo quality (e.g., by reducing reverberations within the lumen).
The receiver may be a multichannel receiver with beamforming and/or pulse
compression for coded excitation.
For example, various arrays and operation thereof, are bed in Ebbini, et al.,
Mode Ultrasound Phased Arrays for Image—Guided Surgery,” Ultrasound
Imaging, vol. 28, pp. 65—82 ; Ballard, et al., “Adaptive Transthoracic Refocusing
ofDual—Mode Ultrasound Arrays,” IEEE Transactions on Biomedical Engineering, vol.
57, no. 1, pp. 93—402 (Jan. 2010); and Wan et al., “Imaging with Concave Large—
Aperture Therapeutic Ultrasound Arrays Using Conventional Synthetic—Aperture
Beamforming,” IEEE Transactions on Ultrasound, Ferroelectrics, and ncy
Control, vol. 55, no. 8, pp. l705~l7l8 t 2008), which are all hereby incorporated
by reference herein.
PCT/U52012/033584
A flow chart of an exemplary ultrasound imaging method 30 for vascular imaging
is depicted in One will recognize that one or more of the blocks of functionality
described herein may be d out using one or more programs or routines, and/or any
other components of an imaging system (eg, the imaging system 10 of and/or
therapy system (e.g., the therapy system 20 of .
1831 Generally, the method 30 provides for the capture of echo data at a sampled
flame rate (block 32). In one embodiment, ultrasound pulse—echo data is provided of a
region in which at least one portion of a blood vessel is located. For example, the pulse—
echo data may be pulse—echo data sampled at a frame rate such that measured
displacement of the vessel wall defining the at least one portion ofthe blood vessel and
measured average blood flow through the at least one portion ofthe blood vessel have a
quasi-periodic profile over time to allow motion tracking of both the vessel wall and the
blood flow simultaneously. r, the method es applying speckle tracking
(block 34) to the pulse~echo data to allow, for example, the generation of strain and shear
strain image data.
As set forth herein with respect to the system shown in Figure 1, one or more
vascular characteristics, e.g., flow characteristics associated with the flow through the
blood vessel 50, structural characteristics associated with the blood vessel 50, and/or
hemodynamic characteristics, may be identified (block 36) based on the tracking of
motion in the vessel wall and flow. In one embodiment, due the simultaneous e of
displacement fields in both the flow and vessel wall, e.g., during a ic cycle, such as
a cardiac cycle, one or more vascular characteristics which depend on ements
resulting from or ng to both such types of displacements (e.g., such as
hemodynamics) may be determined.
Still further, as shown in Figure 2, optionally the method 30 may include delivering
therapy based on one or more vascular characteristics (block 38). For example, as
described with respect to the system of Figure 1, delivery of y may take one or
more different forms (e.g., drug, ablation, surgical, or any other invasive or non—invasive
treatment).
PCT/U52012/033584
In one or more embodiments, the method may include MZD mode imaging
designed to ze the lateral extent of the imaged region at sufficiently high frame
rates to e the full dynamics ofthe vessel wall and the flow within the vessel. MZD
mode produces 2D beamformed RF echo data fiom a selected region ofthe field of view
(FoV) of a given probe. The region may be contiguous or comprised ofmore than one
disjoint subsegments. As an example, on the SonixRP scanner (Ultrasonix, BC, Canada),
an ary set of A-lines within the FoV can be used to form the MZD mode image
with frame mode approximately MB/MMgp higher than B-mode imaging, where M3 and
MW]; indicate the number of A—lines used to form B—mode and MZD—mode images,
respectively.
As shown in Figure 4, M2D mode imaging may be enabled by creating a powerfiil
ned execution/flow program architecture capable of employing a variety of
computational resources for real-time implementation. In addition, the program
architecture may allow the user to invoke additional computational resources available
on the computer (or generally on the Internet) to achieve other computational tasks. The
results from these computations can be integrated seamlessly with the program. For
example, the beamformed RF echo data may be transferred in real time h a
Gigabit ace to allow real—time 2D axial strain computations using GPU (or FPGA)
using 1D speckle tracking. However, the beamformed RF data is available for additional
processing using, for example, a pre—installed MATLAB engine. The MATLAB results
can be imported back seamlessly to the MZD mode g program with minimum
latency (e.g., after the completion of the MATLAB calculations). This capability may
allow us to perform real—time 2D speckle tracking to enable strain and shear strain in the
ty of the vessel wall, e.g., heavy—duty MATLAB-based ations are performed
on a small Rol allowing for their incorporation in real time. In at least one embodiment,
true 2D speckle tracking approaches may be implemented in real time as is tly the
case with 1D speckle tracking. In this way, a pipelined program execution architecture
may be implemented to support MZD imaging which allows us to reap the benefits of
powerful computational tools for the analysis ofthe vessel walls in quasi ime.
The high frame rate MZD mode preserves the correlation to produce well—behaved
2D displacement/velocity profiles to allow for robust strain ation. High quality
2D ) strain and shear strain fields produce views ofthe vessel wall boundaries on
—26-
PCT/U52012/033584
both sides of the vessel in the axial view. Further, they may also produce better
definition of the wall in the lateral direction in the cross—sectional View. This may allow
for measurements ofwall thickening, an early sign of atherosclerosis.
194] Still further, the high quality 2D ; i.e., over time) strain and shear strain will
allow for tissue property measurements within the vessel wall, e.g. ess. Such tissue
property measurements will allow for the characterization of the disease state and, given
the high resolution, the plaque architecture (e.g., base, lipid core, and fibrous or calcified
cap). Therapy or treatments may be red based on such information or such
ation may be used during the delivery of such y (e.g., high ity focused
ultrasound treatments that target the base of the plaque without damage to the cap or
even the lipid core, ual determination ofthe response oftissue to therapy, such as
between doses ofhigh intensity focused ultrasound, etc.).
The pulse~echo data may be provided using any imaging system (e.g., the imaging
system 10 of, although one or more imaging systems may be advantageous over
others. In one or more embodiments, the data acquisition may be performed by an
imaging system 100 such as shown in Figures 3 and 4. For example, as shown in Figure
3, the g system 100 may be used to acquire and perform real—time processing of
such acquired data. The imaging system 100 may include an ultrasound scanner 102
(e.g., a Sonix RP (Ultrasonix, Canada)) loaded with a program used for high frame rate
pulse—echo data collection. The ultrasound scanner may include es such as chirp
generation, waveform generation, data collection, and data transfer capabilities.
[961 As shown in the exemplary embodiment, collected data may be streamlined to a
controller PC 104 through, for example, Gigabit Ethernet for real—time data processing.
The data processing computer 104 can handle the intensive computations required by
high—resolution (both l and temporal) speckle tracking and separable 2-D post—
filtering by utilizing a many—core graphics processing unit 106 (6g, GPU; nVlDlA,
Santa Clara, CA). The ultrasound scanner 102 may operate in B mode for image
guidance (e.g., producing a B-mode image) and in M2D mode for high-frame—rate data
collection. The MZD mode achieves ame—rate imaging by limiting the number of
scan lines to the region of st (ROI), as defined by the user. MZD data may be used
for e tracking. For example, in one embodiment, MZD-mcde acquisition with 10
PCT/U52012/033584
A lines per frame at 1000 fps may be performed. For example, a linear array probe (e.g.,
LAl4—5/3 8) may be used for data collection at a frame rate of 1000 fps in MZD mode by
ng the number of scan lines to 10 and the imaging range to 40 mm. In one or more
embodiments with coded excitation, M2D~mode may collect data at fi‘ame rates from
2000 to 5000 frames per second or more.
In the embodiment shown in Figure 3, high ity focused ultrasound (HIFU) is
also possible (e.g., for generating ound for treatment or subtherapeutic mechanical
and/or thermal s). As such, a VirtexZPro (Xilinx, CA) field-programmable gate
array (FPGA) board 108 is dedicated for HIFU source and synchronized frame trigger
tion. This implementation allows an interference-free data collection by briefly
silencing the HIFU generator while pulse-echo imaging is active.
Speckle tracking used for imaging herein relies on accurate estimation of
incremental frame—to—frame time shifts, which are typically much smaller than RF—echo
sampling period. In one embodiment, a 2-D complex correlation oftwo subsequent
flames of pulse-echo data is carried out. The real—time data processing engine 110 is
based on a GPU 106 with a large number of cores (e.g., a GTX285 GPU with 240
processing cores and designed to take full advantage of its highly parallel architecture).
Implementation of real—time processing is supplemented with ated Performance
Primitives (Intel) and Matlab tools 112, 114. Further, a research interface system 120 is
provided for operator control.
Figure 4 shows an ary block diagram of a GPU-based implementation 130
for an imaging , such as shown in Figure 3. In one embodiment, for each
processing stage, fine—grained partition is performed for the algorithm in a data-
independent manner so that all 240 sors are working efficiently on individual
blocks of data.
For example, Figure 4 shows one exemplary embodiment of a real—time signal
sing chain of rmed ultrasound data for strain imaging (e.g., shown for 1D,
but which can be generalized to 2D or 3D). The real-time speckle tracking is performed
in the axial direction, but axial strain and axial shear strain can be performed in real—time
as a first step to identify the vessel boundaries (e.g., this has been tested in vivo on
~28—
PCT/U52012/033584
vessels of various diameters (~1 mm in rat) and (~4 mm in swine)). The 2D strain
calculations can be performed in a region—of—interest (ROI) around the identified blood
vessel. Axial and lateral strains and corresponding shear strains can be calculated in
real—time following this step. Furthermore, direct estimation of s and shear strains
in the ate vicinity of the vessel wall may be provided. For both 1D and 2D
versions ofthe strain calculations, additional sing in the time direction will fiirther
define the vessel boundaries and the internal boundaries of the wall. For example, in the
context of imaging atherosclerosis, this may yield the internal composition of the plaque.
As shown in Figure 4, on the CPU side, data can be come from Network Stack
(e.g., experimental mode, where data is streamlined fiom SonixRP scanner) or Data File
(e.g., review mode). The sed result can be ized with a designed U1 system
(OpenGL based) or exposed to other commercial sofiware for fiirther analysis (e.g.,
Matlab). The result can be also used in feedback control for ime ature
control.
On the GPU side, Figures 4 shows a GPU-based entation ofthe algorithm
described in (see, e.g., Simon, et al., imensional Temperature Estimation Using
stic Ultrasound,” IEEE Transactions on Ultrasonics, Fen'oelecn'onics, and
Frequency Control, vol. 45, no. 4, pp. 1088-1099, JULY 1998). The various blocks
shown in Figure 4 have at least the following functionality: Hilbert transform: computes
the analytic signal of the RF echo using an FIR Hilbert Transformer; Cross
correlation/Phase projection/Accumulate: implements 1D version of speckle tracking;
2D Separable Filter: allows temperature estimation (e.g., thermal strain computation);
Bilinear Interpolation: provides hardware accelerated olation for data Visualization;
and Local Storage: provides data management in GPU domain.
In other words, in one or more embodiments, a system for vascular imaging is
provided herein that includes one or more ultrasound transducers (e.g., wherein the one
or more ucers are configured to r ultrasound energy to a vascular region
resulting in pulse-echo data therefrom) and processing apparatus (e.g., including one or
more programs able by one or more processors ofthe system to perform one or
more functions thereof and as described herein, such as control of data frame acquisition,
speckle tracking, visualization, image generation, characteristic identification, etc)
PCT/U52012/033584
In other words, the processing apparatus (e.g., GPU, CPU, etc.) may be configured
(e.g., e under control of one or more programs) to, for example, control the capture
of pulse-echo data at a flame rate such that measured displacement of a vessel wall
g at least one portion of a blood vessel in the vascular region and measured
average blood flow through the at least one portion of the blood vessel have a quasi—
periodic profile over time to allow motion ng of both the vessel wall and the blood
flow simultaneously; generate strain and shear strain image data for the region in which
the at least one n of the vessel is located using speckle tracking; and identify at
least one vascular teristic of the vascular region in which at least one portion of a
blood vessel is located based on the strain and shear strain image data (e.g., wherein the
at least one vascular characteristic comprises at least one of a flow teristic
associated with flow through the blood vessel, a structural characteristic associated with
the blood vessel, and a hemodynamic characteristic associated with the blood vessel).
Further, for example, processing tus may be configured to use e
tracking of one or more speckle s of the vascular region in which at least one
portion ofthe blood vessel is located to track motion of both the vessel wall defining the
at least one portion of the blood vessel and the blood flow through the at least one
portion ofthe blood vessel (e.g., n the pulse—echo data is captured at a frame rate
such that displacement of the vessel wall defining the at least one portion of the blood
vessel and blood flow through the at least one portion ofthe blood vessel are measurable
simultaneously within a same periodic cycle corresponding to a cardiac pulse cycle
and/or identify at least one vascular characteristic of the vascular region in which the at
least one portion of the blood vessel is located based on the simultaneously measured
displacement of the vessel wall and average blood flow. Further, for example, the
processing apparatus is further le (e.g., by ing one or more programs) to
generate strain and shear strain image data for the region in which the at least one portion
ofthe vessel is located using the speckle tracking (e.g., wherein the speckle tracking
includes using multi—dimensional correlation of sampled pulse—echo data ofthe one or
more speckle regions undergoing deformation in the region in which the at least one
portion of a blood vessel is located, wherein the multi—dimensional correlation comprises
determining a cross—correlation peak for the sampled pulse—echo data based on phase and
magnitude gradients ofthe cross-correlated sampled pulse-echo data).
PCT/U52012/033584
As shown in Figures SA—SD, in one or more embodiments, the flame rate at which
pulse echo data is acquired should be at least greater than 100 fps, and even greater than
200 fps. In at least one embodiment, the flame rate is greater than 300 fps. The frame
rate should be sufficiently high for reliable motion tracking in both tissue and blood
onously (e.g., such that measurements relating to the same are relevant to the same
time frame or periodic cycle). For example, in one embodiment, the MZD mode allows
for providing a high flame rate while maintaining the correlation at high levels to
produce smooth and uous displacement /velocity fields (e.g., displacement of
tissue, motion of blood flow) to allow for robust strain and shear strain determinations.
The flame rate for acquiring pulse—echo data should be adequate to provide
displacement fields in both flow and tissue that are well~behaved. In one embodiment,
such well—behaved cement can be identified by the ements of channel
er related to tracking oftissue displacement (e.g., vessel wall displacement or
motion) and average flow velocity related to the tracking offlow through the vessel (e.g.,
tracking ofblood flow through the blood vessel) over time. As such, Figures SA—SD
show graphs ofboth the tracking offlow in a vessel (cg, represented by the change of
average flow velocity shown in solid lines) as well as the tracking of vessel tissue
cement (e.g., represented by change in channel diameter over time shown by
dashed lines) for multiple flame rates. Figure 5A shows determinations for a flame rate
of40 fps; Figure SB shows determinations for a flame rate of 81 fps; Figure 5C shows
determinations for a flame rate of 162 fps; and Figure 5D shows determinations for a
flame rate of 325 fps.
It is clear flom Figures 5A and 513, that such low flame rates (e.g., less than 100
fps) do not e measured displacement ofthe vessel wall defining a blood vessel
and measured average blood flow h the blood vessel which are well behaved. In
other words, measurements of flow and tissue displacement (e.g., vessel wall
displacement) could not be accurately ed simultaneously. For example, as clearly
shown in Figures 5A and SB, the blood flow is shown to be rather random throughout a
periodic cycle of the displacement of the vessel wall represented by the channel diameter
information (e.g., flom peak to peak of the vessel wall displacement). In other words,
such blood flow data is ridden with artifacts making an accurate flow determination
PCT/U52012/033584
difficult during the cycle. Even the vessel wall displacement information appears to
include some cts.
However, discernible from s 5C and 5D, at higher frame rates (e.g., r
than 100 fps) the measured displacement ofthe vessel wall defining a, blood vessel and
measured average blood flow through the blood vessel are well d such that
ements of flow and tissue displacement (e.g., vessel wall displacement) could be
accurately measured synchronously (e.g., corresponding to the same time). For example,
as clearly shown in Figures 5C and 5D, the blood flow is shown to be much less random
throughout a periodic cycle ofthe displacement of the vessel wall represented by the.
channel diameter information (cg, fiom peak to peak ofthe vessel wall displacement).
In other words, the measured displacement of the vessel wall defining a blood vessel and
measured average blood flow through the blood vessel have a quasi-periodic profile over
time which allows motion tracking of both the vessel wall and the blood flow
simultaneously. Note the strong peaks for both the channel diameter and average flow
velocity within the same periodic cycle (e.g., corresponding to the cardiac cycle).
As used herein, the term quasi—periodic profile is meant to reflect a profile that is
substantially consistent over periodic cycles in the form of a regularized pattern, even
though there will be some variation on a frame to frame basis, e.g., periodic cycles
corresponding to cardiac cycles. For example, such a quasi—periodic profile for flow
ty may e strong peaks during each cycle indicating maximum flow followed
by flow measurements that indicate little or no flow during the remainder ofthe cycle.
Further, for example, such a quasi—periodic profile for channel diameter may include
strong peaks during each cycle indicating maximum displacement of the vessel wall
followed by measurements that indicate a relaxation ofthe vessel to a normal state
during the remainder of the cycle. Such a flame rate that results in a periodic
profile allows for tracking of flow and vessel displacement simultaneously, or in other
words, synchronously with each other (e.g., in phase with each other).
The frame rate may vary depending on various s. For example, the frame rate
may be based on the vessel structure (e.g., carotid artery versus peripheral vein), timing
ofthe periodic flow through the vessel (e.g., pulse cycle length), motion of the vessel
structure (e.g., time for vessel to relax to normal); depth ofthe target vessel (e.g., deeper
PCT/U52012/033584
vessels may be imaged at lower frame rates), use of coded excitation (e.g., coded
excitation may allow for increased flame rates), and the f—number of imaging focus (e.g.,
higher f-numbers may result in reduced lateral resolution), etc.
Still further, in one or more embodiments, higher flame rates may be accomplished
when coded excitation ultrasound is used. Such coded excitation ultrasound is
bed, for example, in the literature and will not be discussed in detail herein. For
example, one or more rative examples of coded excitation ultrasound which may be
used in ation with the g method and/0r systems described herein are
provided in Shen et al., “A New Coded-Excitation Ultrasound Imaging System———Part I:
Basic Principles,” IEEE ctions on onics, Ferroelectrics, and Frequency
Control, vol. 43, no. 1, pp. 131 —140, Jan. 1996); Shen et al., “A New Coded-Excitation
Ultrasound Imaging System--—Part II: or Design,” IEEE Transactions on
Ultrasonics, Ferroelectrics, and Frequency Control, vol. 43, no. 1, pp. 141 ~148, Jan.
1996); and Shen et al., “Filter~Based Coded—Excitation System for High-Speed
Ultrasound hnaging,” IEEE Transactions on Medical Imaging, vol. 17, no. 6, pp. 923—
934, Dec. 1998), which are all incorporated herein by reference.
In one or more embodiments, the frame rate may be greater than 100 fps, greater
than 200 ips, greater than 300 fps, greater than 500 fps, greater than 1000 fps, and even
greater than 5000 fps. In other embodiments, the flame rate may be less than 5000 ips,
less than 4000 fps, less than 3000 fps, less than 2000 fps, less than 1000 fps, less than
600 fps, less than 500 fps, less than 400 fps, less than 300 fps, or less than 200 fps. In at
least one embodiment, the frame rate is within the range of 100 fps to 5000 fps.
As shown in the imaging method 30 in Figure 2, speckle tracking is applied to the
pulse-echo data (block 34). For example, strain and shear strain image data for the
region in which at least one portion ofthe vessel is located may be generated using
speckle tracking. In one or more embodiments, the speckle tracking may include using
multi—dimensional correlation of sampled echo data of one or more speckle regions
(e.g., windows) undergoing deformation in the region in which the at least one portion of
a blood vessel is located. The multi-dimensional ation may include ining a
cross-correlation peak for the sampled pulse-echo data based on phase and magnitude
gradients ofthe cross-correlated sampled pulse—echo data,
PCT/U52012/033584
Such generation of strain and shear strain image data allows for the identification
of at least one vascular characteristic ofthe region in which at least one portion of a
blood vessel is located (block 36) (e.g., a flow characteristic associated with flow
through the blood vessel, a structural characteristic ated with the blood vessel, a
hemodynamic characteristic associated with the blood vessel, etc). One or more types
of strain and shear strain image data may be used and/or ized to identify such
vascular characteristics.
Strain calculations include performing band-limited gradient calculations on the 2D
(or 3D) displacement fields obtained using speckle tracking (in 2D or 3D). ime
speckle tracking on full image sizes (i.e., for every pixel of the RF echo data) may be
achievable in the axial direction. 2D and 3D speckle tracking may be achieved in real
time in a region of interest around the blood vessel. The strains and shear s can be
overlaid on B-mode or other ound imaging formats. For e, information
regarding such ations are also found in Liu et al., “Real-Time 2-D Temperature
Imaging Using Ultrasound,” IEEE Transactions on Biomedical Engineering, vol. 57, no.
1, pp. 12—1 6 (Jan. 2010), which is hereby incorporated by reference herein.
For example, generation of strain and shear strain image data for the region in
which the at least one portion ofthe vessel is located using e tracking may include
generation of at least one of axial strain and/or axial shear strain image data (e.g., axial
relating to the axis through the vessel being imaged). Further, such generation of strain
and shear strain image data may include generation of lateral strain and/or lateral shear
strain image data. Such data may be visualized, for example, in both longitudinal views
(e.g., along the blood vessel) or cross-section views (e.g., orthogonal to the axis ofthe
blood vessel), as fithher provided herein.
For example, one or more types of strain and shear strain image data may be used
and/or visualized to identify one or more vessel wall boundaries, including the vessel
wall boundaries around the entire blood vessel (e.g., such boundaries may be visualized
in cross-section and/or measured about the entire blood vessel). One or more other
vascular characteristics may be fied, measured or calculated therefrom, such as
tissue property within the one or more vessel wall ries, one or more portions of a
plaque architecture adjacent the one or more vessel wall boundaries, and/or one or more
PCT/U52012/033584
hemodynamic measurements based on both the motion tracking ofthe vessel wall and
the blood flow simultaneously.
Certain types of strain and shear strain image data may be more beneficial for
imaging one or more portions ofthe blood vessel and flow therethrough than others. For
example, axial strain image data may be beneficial in identifying a first set of opposing
wall boundaries (e.g., on opposite sides of the vessel) while the axial shear strain image
data may be beneficial in identifying a second set of opposing wall ries (e.g., on
opposite sides of the vessel) such that the boundaries ofthe entire vessel (e.g.,
discernible in cross-section) can be identified. Further, the same is generally the case for
lateral strain and lateral shear strain. Further, for example, the lateral shear strain may be
beneficial in providing wall shear stress data (e.g., used for identification of le
plaque formation).
Further, for example, shear strain images fiirther define the vessel walls, not only
the proximal and distal walls, but also the side walls, which are hard to see on
conventional ultrasound. (2D/3D+Time) calculations may also be used to refine the
detection ofthe wall boundaries as a function of time during the heart cycle.
The speckle tracking applied to the pulse—echo data (block 34) may include using
any multi-dimensional correlation of d pulse-echo data of one or more speckle
regions (i.e., windows being tracked). For example, two—dimensional correlation of
sampled pulse-echo data of one or more speckle s may be used, as well as other
multi-dimensional correlation ques.
In one embodiment, for example, speckle tracking is performed as described in E.
S. , “Phase—coupled two—dimensional speckle tracking algorithm,” IEEE Trans.
Ultrason, Ferroelect., FI'eq. Cantu, vol. 53, no. 5, pp. 972—990, May 2006 (hereinafter
“Ebbini 2006”), which is incorporated herein by reference. For e, in general,
such speckle tracking includes coarsely searching the magnitude of the sampled pulse-
echo data in a lateral and axial ion to locate a vicinity of the cross-correlation peak
within the cross—correlated sampled pulse—echo data; determining, within the vicinity of
the correlation peak, at least two opposing gradient vectors in proximity to the
cross—correlation peak; determining, within the ty ofthe cross—correlation peak, a
PCT/U52012/033584
zero—phase line ofthe cross—correlated sampled pulse—echo data; and using the at least
two opposing nt vectors in proximity to the cross—correlation peak and the zero—
phase line to estimate the correlation peak.
More specifically, as described in Ebbini (2006), a two—dimensional (2-D) speckle
tracking method for displacement estimation based on the gradients ofthe magnitude
and phase of2—D complex correlation in a search region is provided. This approach
couples the phase and magnitude nts near the correlation peak to determine its
coordinates with subsample accuracy in both axial and lateral directions. This is
achieved with a minimum level of lateral interpolation determined from the angles
between the ude and phase gradient vectors on the sampled (laterally interpolated)
2-D correlation grid. One result behind this algorithm is that the magnitude
gradient vectors’ final approach to the true peak is orthogonal to the zero—phase contour.
This leads to a 2-D robust projection on the zero—phase contour that results in subsample
accuracy at interpolation levels well below those needed. r, the approach includes
a robust fast search thm that allows the localization of the true peak without the
need for exhaustive search.
In other words, the speckle tracking uses the phase of the 2-D complex cross
correlation for robust and efficient estimation of displacement from speckle data. This
speckle tracking method finds the true peak ofthe 2—D complex cross correlation as a
constrained optimization problem. The ive of this optimization problem is to find
the coordinates ofthe axial and l lags at the true peak ofthe 2—D complex cross
correlation subject to the zero~phase constraint. The basis for this formulation is shown
mathematically from the inverse of the Fourier transform of the 2—D cross spectrum near
the true correlation peak. This geometric approach finds both the axial and lateral
displacement estimates with subsample accuracy. The method is based on the fact that
the gradient vectors ofthe magnitude ofthe 2*D cross ation ch the true peak
along the orthogonal to the zero—phase contour. Knowing that the zero~phase contour
also passes through the true peak, it is possible to locate this peak simply by finding the
point on this r at which the magnitude gradient vectors are orthogonal, provided
these s ate from a grid point that is sufficiently close to the peak. One
feature of this algorithm is that interpolation ofthe complex cross correlation is used at a
minimum level that allows for a valid projection to be made. Therefore, the algorithm is
—36—
PCT/U52012/033584
computationally efficient in terms of determining the level of olation needed for
subsample accuracy from the properties ofthe underlying 2—D, cross—correlation
function, not from the desired lateral resolution.
The following is a mathematical basis for correlation-based 2—D speckle tracking
and relates it to a 2-D cross spectrum approach. Thereafter, two implementations of a
phase-coupled 2—D speckle ng algorithm are then provided.
Let s(x, z, to) be the analytic ultrasonic signal ed from a 2-D region (e.g.,
speckle region or window) at time to with spatial coordinates x and 2 representing the
l and axial directions, respectively. The received signal model assumes a linear
space-invariant imaging system with rectangular sampling (e.g., linear array). Afier
undergoing translation dx and d; (respectively in the x and 2 directions), the received
signal at time, t], 5(x, 2, 1]) == s(x - a}, z - dz, [0) has a 2—D Fourier transform:
(kx,kz,t1) :3 SW“kg?tow—J(ismdab-+iczdg,,)a (1)
where In[ and k; are the l fiequency variables (in rad/m) in the x and 2
directions, respectively. The 2—D cross spectrum is given by:
F12U’v’m [92) II 51km, kt1)5*(lfim 162,160)
a ligament?attests“
[130} Motivated by this equation, one investigator developed an algorithm based on the
2—D cross um for estimation of fine displacement in both the axial and lateral
directions. An iterative weighted least squares approach to estimate the slopes of the
axial and l frequency components has been proposed. However, a more efficient
on to this problem can be obtained by finding the true peak ofthe 2-D cross—
ation function, given by (3) and (4),
PCT/U52012/033584
1 m 00
was, a). =
4W2 f
112031 anaemia:“WE-warning
~00 - -OO/
1 90 .00
. ‘ a
“ —0c) 4—00
I {"1102} “ (11'qu ~— dz); (4-)
where [X and l; are the lags in the x and 2 directions, respectively. This function peaks at
lag values equal to the shift values in both the axial and lateral directions. This result
drives all correlation-based, 2-D displacement tracking methods. However, with the use
of sampled correlation functions due to the te nature ofthe RP data collection, the
true correlation peak must be found with subsample accuracy. This is especially true for
the lateral displacement estimation in which the sampling interval (spacing n A—
lines) is on the order of 10 times the axial ng interval.
Insight into this problem can be ed by evaluating the cross—correlation function in
the vicinity of the true peak where kx(lx — dx) 3 0 and kz(lz - dz) : 0, from (3):
1 m
/w lSC‘km: 13241301) [Eli +Jlk9:(l:z: “, .
7.12 (£33,. £3) % (lat)
4W2 /
+ Axdz ~w d3)])c‘lfflxdffiz (5)1 ‘
: 7'11“): 0) +jmiaszam " dm) “l‘ Alexa: ”" (33)]:
Where:
1 DO 00
4"V f
|S(km,kx,»tollzkmdkmdkg,,
~00 / -00 <6)
1 ‘00 GO
Mm: . o
,2 f [swamkz,t0)|“k:gdkmdkz. (fr).
4' 5T“
~00./-o<::
PCT/U52012/033584
[137} The factor MJG is d to the mean lateral frequency ofthe 2—D auto spectrum.
rly, the factor MEX is related to the mean axial frequency ofthe 2—D auto spectrum.
Due to the fact that the axial component in many coherent imaging systems has a carrier
and that the complex envelope is used, {My} :3) 0. This modulation property does not
exist for the lateral factor Mm and its magnitude is generally small. It is important to
note, however, that in a speckle environment, [M15] 99 O (typically lMgl 33> [szly The
result in (5) can be seen as a lization of a 1—D e tracking case in which the
slope ofthe phase curve is equal to the center fiequency ofthe (analytic) echo signal [8].
In fact, expressing (4) in vector form (and including the quadratic phase term in the
Taylor series expansion ofthe exponential), we get:
’l"1a(1)=-%§W/-:f"raring-tweak3 k a}) 9531‘(Idildk s
/an:to))1(1+jk’(lwde7X}
éfldll — dXJJ2Jall:
. n m na,
a —— E(1 __ dx) [M
__ thfi) (1— (1):)
W.;]
+ j [M Mm] (1w ax)’ (9).
where the elements Wxx, sz, Wm, WZZ are given by:
PCT/U52012/033584
1 DC? (1351)
Hi =
4,.2 /N / [SlkmEchtgjlzkidkmdkm
”(X3 ' _m (10)
1 00 DO
. ‘ '
Wm = 1.90%,k3,tg)|2isgfdkmdkz,
4W3 /“
. -m mf In)
Him: 2 film;
1 0‘3 PO .
,. .
t—co ~
. wot:
Note that Wxx is related to the lateral frequency bandwidth of the imaging system.
It is easy to 866 that y12(dx, dz) = m0, 0) > 702(1):, la W1» 1:) 7": dz: 619- Also note that
, dz) is real, which implies that the true peak of the 2~D cross ation must lie on
the ase contour defined by:
Zfif‘igamazy) % flif 3% - (ix) + lid—331a}; __ dz),
[firm him] (1- dx) : m’fl — (IX); (13)
However, based on the above approximation, the magnitude ofthe 2D cross
correlation is given by:
W120“ I
V” {711(010) ~— (1* dx)"W(1 —— that»2 +(111'(1 — dx))2j
{14)
for which the ose of the gradient vector can be evaluated as shown in (15), which
indicates that the gradient is identically zero at the true peak (1 = dx) as expected.
617120)! —2 («(1,0) — (1 - dx)'W(l .. dx» (1_dx),w + (111,0 _ dx)) m,
= (15)
\/(')‘11(0, 0) — (1— dx)’W(l — dx))3 + (111’(l , CRUZ
PCT/U52012/033584
Furthermore, the magnitude of the magnitude gradient near 1 = dx is proportional to
the distance from the true peak, i.e., the closer the grid point to the true peak, the smaller
the magnitude of the gradient. In addition, ifthe grid point is such that l — dx is
orthogonal to m (m ’(l — dx) = 0), then the magnitude gradient is orthogonal to m, and
the true peak can be obtained by finding the intersection ofthe line along the magnitude
gradient with the tangent to the zero phase contour. Of course, this is only valid when
the grid point is sufficiently close to the true peak. This can be determined from the
ude of the ude gradient on the grid. This result provides us with insight for
approach to determine the true peak of the 2—D cross-correlation function fiom a grid of
computed values around the peak. Specifically, by comparing the slope ofthe minimum
magnitude gradient with the slope ofthe phase contour in the Vicinity of the peak, one
can ine whether the true peak is sufficiently close to the grid points to make a
valid approximation.
This leads to algorithms as described herein for finding the true peak that are both
robust and numerically efficient in the sense that interpolation is used at a minimum
level to ensure the ions of a valid projection onto the zero—phase contour. The
formulation bed herein also provides the basis for an zation procedure of
finding a point on a quadratic surface (magnitude of the 2-D cross correlation) subject to
the zero—phase condition. This problem can be solved using the Lagrange multiplier
method as described herein.
The above result can be easily extended to the case of affine transformation [13]:
3(X1,t1) = 5(X0(X1:)3t0)3 (16,}
where:
X0: = Txl ~— th (17')
(3:33- :750‘ (3511:
1 +523] 3 (1'8)
63113
r—w-fiNHMy» M l 1 + 3mm[ [:33] w [dz]
which accounts for translation (dx), strain (em- and egg), and shear strain (ex,— and ea).
PCT/U52012/033584
In this case, we use the Fourier transform of the received signal at time A in vector form:
arm) = 3(1)f k, talefl jfika. ldx) /}T1,, . :19)I
where T’ is the ose of T and I - ] is the determinant of a matrix. Note that
(19) is just a generalization ofthe scaled property ofthe r transform in 1—D, which
has previously been used in the analysis of decorrelation asonic echoes in the
presence of strains. It is also consistent with the 2—D/3-D ation shown in [5],
which analyzes the combined effects of ation and waveform warping on the
variance of the displacement estimate.
It suggests that both axial and lateral strains can affect the displacement estimates
based on phase matching alone. It also may provide an opportunity to directly (or
iteratively) estimate the strains on the tissue region interrogated by the . We note
here that, in cases in which the strain parameters, em ex, ex, and ex, have non-negligible
values, the zero-phase contour does not necessarily go through the true peak ofthe
magnitude ofthe 2-D cross correlation. To illustrate this point, (19) can be written
explicitly in terms of the shift and strain parameters as shown in (20), which shows that
the scaling ofthe Fourier transform in the kx and k: nates is coupled through the
shear strain parameters. Amplitude scaling leads to decorrelation effects previously
reported for 1~D tracking. Furthermore, the ted shift from the zero—phase contour
is also coupled, i.e., a shift in the x direction contributes to the estimated shift in the z
direction and vice versa (through the shear strain ters). The simple result given
by (5) is only approximately valid for infinitesimal s within the tracking window.
Fortunately, (20) provides a method to detect when the strain effects Within the window
are significant enough to affect the phase estimation.
“emzka: + (i + ex.z)kz
3(1‘33151‘721“) _ 11S ((1 +€zz)}'3:c “ 5::ka to) ' IT lTl ’ lTl 7’
‘i' 3:3)d3: "’ szdz)kx + ((1 “l" 6:7:m)d3 __C:E'C§Q£SZ) (20)
~e (((1 ”7|
{157]
PCT/U52012/033584
In the speckle tracking method, one is interested in the use ofphase—coupled
approach in finding the true peak ofthe 2-D cross—correlation function when the tissue is
undergoing cement and/or infinitesimal strains. This can be considered a first step
in estimating the displacement vectors needed in applications such as, for example,
vector velocity estimation and elastography. Such applications may require
displacement ng based on the peak ofthe 2-D cross ation as a common step,
but they may differ in the deformation model parameters used. This can be done by
implementing a post-processing step that extracts the deformation ters from the
shift estimation results ed from finding the true peak of the 2-D cross correlation.
Such post-processing depends on the specific problem to be determined.
An Exemplary Phase~C0upled 2-D, Speckle Tracking Algorithm
The steps ofthe ary speckle tracking algorithm are guided by the properties
ofthe 2—D correlation of the speckle region undergoing motion and/or deformation. The
magnitude of the 2—D correlation with the complex envelope has a well behaved peak
with extent in axial and lateral directions proportional to the speckle cell size. The main
idea is to use a fast search algorithm to find a correlation-based match within a search
Window (i.e., correlation values above a threshold). Ifthe current search point is far
from the correlation peak, a fast search can be used with axial and lateral steps on the
order of one-halfthe extent ofthe correlation cell size in the axial and lateral directions.
This allows the search to coarsely cover large regions without missing the true peak (if it
exists). Once a match is found, the magnitude gradient of the cross correlation is used to
find the peak cross correlation on the sampling grid (determined by the RF sampling
frequency and spacing between the Aalines in the image). This is done by following a
gradient ascent trajectory, which requires two to three correlation values to be computed
for every point along the tory. nt search for the peak is very robust and
efficient from any direction if search point is within the width of the ation peak in
the axial and lateral ions, e.g., within 3 dB from the peak. Once the grid-based
correlation peak is found, a 3 X 3 ation grid is calculated (centered at the peak). In
the immediate vicinity of the correlation peak, the true peak can be determined from the
magnitude nt vectors and the zero-phase contour passing the true peak. From the
3 X 3 grid in the original sampling coordinates, a fine estimate of the true correlation
PCT/U52012/033584
peak is produced by coupling the phase of the 2—D cross correlation to the amplitude
(gradients) in a way that will allow us to use (13).
Two exemplary ches for obtaining the fine estimates are described in the
following subsections.
A. Two—Dimensional Projection on the hase Contour
This method interpolates the 3 X 3 grid near the true peak in the lateral lag
direction by a sufficiently large factor (i.e., as small as possible) in order to estimate a
magnitude gradient vector onal to the zero—phase contour. The intersection ofthe
magnitude gradient and the zerophase contour is the estimated true peak of the 2—D cross
correlation.
The steps ofthis algorithm are outlined as follows.
Step 0: From the 2-D autocorrelation function at to, estimate the search step size L;
and 13I in the axial and lateral directions, ly. Typically, L: > 1LI due to the finer
sampling in the axial direction.
Step 1: Perform any fast search algorithm to find the vicinity of correlation peak
(above a threshold) using L;r and L: in a defined search region.
Step 2: Without any interpolation, compute the local magnitude gradient and move
along the gradient ascent trajectory. This step stops when the peak point on the
uninterpolated grid is d.
Step 3: Once the maximum point on the uninterpolated grid is reached, compute
cross—correlation values on 3 X 3 grid centered at the maximum. Interpolate the 3 X 3
grid laterally by a small factor (e.g., 8) and find the line ons for the two gradient
vectors closest to the true peak, but pointing in te lateral directions. If this
condition is not satisfied with the t interpolation factor, increase olation by
two and repeat the test. If maximum interpolation factor is reached (e.g., 128) and
~44.
PCT/U52012/033584
correlation at the olated peak is below a threshold (e.g., 0.75) displacement
estimate is declared invalid and assigned a value ofNaN. Otherwise, proceed to Step 4.
Step 4: Find the line equations for the hase line ofthe ation function on
the olated grid. The estimated true correlation peak is the point of intersection
between the zero—phase line and the orthogonal line that passes through the point of
ection ofthe two maximum—slope lines from the magnitude gradient.
For illustration purposes, the search trajectory in Fig. 6A is based on L, = 1 and L,—
= 5 (from Step 0). Fig. 6A shows contours of the 2-D cross correlation with the search
path shown [starting from (0,0) lag as indicated by the . The it indicates
correlation lags tested by the fast-search algorithm and the - indicates lags tested by the
gradient—ascent algorithm (L. = 1 and L3 = 5). Note that the true correlation peak has a
well behaved set of contours that distinguish it from several false peaks in the search
region shown. rmore, the 0.7 contour extends by approximately 4 lateral lags and
axial lags (which justifies the choice ofL. and L5). Step 1 begins at lag (0,0) and tests
the cross—correlation coefficient. If below the set threshold (0.65 in this case), it moves
to the next point as indicated by the arrow (-1 l and -5 axial). If still below
threshold, it tests correlation values along each pixel on the (predefined) trajectory. In
this case, the predefined search trajectory is along rectangular counterclockwise loops
(dimensions 2 LI rk z'+ 1 2 r» L: 51¢ i + 1 where i = 0, 1, . . . [max is the loop number).
The parameter 1max defines the extent ofthe allowed search region to find a valid peak
(Imax = 6 for the search region shown in Fig. 6A).
In this search example, the eight lags on the first loop are tested, and no candidate
peak is found (i.e., no correlation value > 0.65). The thm jumps from the last point
in the first loop (—l lateral and 0 axial) to the first point in the second loop (—2 lateral
and ~10 axial) and moves counter clockwise along the lateral lag direction. This step
stops once the threshold test is successfiil, i.e., correlation value at the current correlation
lag above the chosen threshold. In Fig. 6A, this step stops at lateral lag 0 and axial lag
~10 after a threshold of 0.65 was reached. Step 2 also is illustrated with the help of Fig.
6A. The - signs at (0, 10), (1, 10)(l, 11), (l, 12), (2, 12), (2, 13), (2, 14) are the
grid points tested by the gradient ascent. The neighboring points of (2, ~ l4) also are
tested before declaring this point as the maximum point on the correlation grid.
WO 42455 PCT/U52012/033584
The final two steps ofthe algorithm may be rated with the help of Fig. 6B
which shows the magnitude and phase contours ofthe interpolated 2~D cross correlation
near the true peak. Further, Figure 6B shows magnitude and phase contours ofthe 2—D
cross correlation on the laterally—interpolated 3 X 3 grid in the vicinity ofthe correlation
peak (between lags — 13 and —15 axially and 1 and 3 laterally). The arrows ent the
magnitude gradient vectors on the interpolated grid. Lateral interpolation by a factor of
16 is used in this case (with the interpolated grid points indicated by the arrow bases).
The phase contours are labeled with phase values in radians and appear to be almost
straight with a small tilt. The true peak is indicated by the open circle on the zero—phase
line. The dash—dotted lines are the directions ofthe magnitude gradient vectors closest to
the peak and the tangent and the orthogonal to the zero—phase line. In addition, one can
see the ude gradient vectors ng in the (general) direction of the true peak.
An interpolation factor of 16 was used for this case between lateral lags 1 and 3 and axial
lags -13 and ~15 (i.e., centered at 2 lateral and —14 axial from Step 2). Four (thick
dash~dotted) lines are drawn along the two closest magnitude gradient vectors, the
tangent to the zero—phase line, and the orthogonal to the zero—phase passing through the
point of intersection of the maximum—slope lines. The true correlation peak, indicated
by the open , is the point of intersection ofthe latter with the zero—phase line.
The final step in the projection on zero—phase algorithm is an approximation ofthe
magnitude gradient vector orthogonal to the zero-phase contour at the true peak. The
approximation error depends on the level of olation used and can be controlled by
using a lateral interpolation factor just enough to ensure that at least one of the two
magnitude—gradient vectors used in the final approximation is not substantially parallel
to the zero—phase contour near the true peak. In l, this conditicn is needed only
when the axial shift is practically equal to integer multiple of the axial sampling interval.
For example, in Fig. 6B one can see the ude gradient vectors at axial lag —14
approaching from the right are almost parallel to the zero-phase line. The interpolation
factor of 16 used here was just enough to produce a valid projection. A valid projection
is one in which the two magnitude gradient vectors closest to the peak intersect the
t ofthe zero—phase line at points in which the tangent approximates the phase
contour well. The key point here, however, is that the olation can be performed
adaptively, thus minimizing any ssary calculations in the cement estimation
PCT/U52012/033584
algorithm. In addition to the computational age of this ch, one can reduce
or eliminate the error due to interpolation.
H7“ It should be noted that one or more different steps may be implemented in the
method, and the specific steps ed herein are not take to be limiting on the
disclosure. For example, the exemplary search algorithm may be implemented using one
or more other l signal processing approaches. Further, for example, for template
matching, one can use the autocorrelation sequence in the vicinity of the (0,0) lag. A
related issue is the ation ofan invalid estimate based on the ation threshold
in Step 3 and assigning a value ofNaN. This can be thought of as a flag to be used in
subsequent processing if necessary. For example, one may use an adaptive window size
to maximize the composite signal-to—noise ratio (SNR). Alternatively, one may use an
explicit ation model similar to that described by (19).
p73 Further, the present disclosure is not limited to use of 2D speckle tracking. For
e, other multi—dimensional tracking methods, such as 3D speckle tracking
methods may also be applicable in one or more embodiments herein.
uvq B. Surface Polynomial Fit with Phase Constraints
pvn The 2—D phase projection approach described above can be thought of as an
efficient method for implementation of an optimization procedure for finding the true
peak ofthe complex 2-D cross correlation. The peak finding problem can be cast as
finding the ients of a polynomial fit to the surface of the magnitude of the 2-D
cross correlation in the vicinity ofthe true peak. The nominal and interpolated contour
plots shown in Figures 6A and 6B are obtained from actual imaging data and are
representative of what can be expected from a standard imaging scanner. It is quite clear
that the e near the true correlation peak is well behaved and appears to be quadratic
in the Ix, [2 space. A polynomial fit to this (smooth) surface is given by:
Qilx la") 2 013:2 + big-2 ‘i’ CAKES + {are + 5Z2 + f:
u7m (21)
PCT/U52012/033584
[mm where [I and I; represent lateral and axial lags, respectively, and q is the magnitude
of the 2—D, x cross ation in the vicinity of the true peak. It is possible to
solve for the polynomial coefficients by minimizing the square error:
Jtfl) = E: (amaze) —- ing, <22)
[mm i=1
[mm where 6 = [a, b, c, d, 3, fl” and N is number ofpoints on the grid (in this case N =
um] This amounts to solving the over-determined system of equations:
um] a=ae mm
' [W12(£mlfilgl)l~
[:312 3'312 Earl [31 Earl Zgl 1 b
hilgaifzzlznjl Z322 11:2 53321-752 £312 £32 1
- d
{34), *
lfl'flizxwwlz‘n'fl. , g 5
lam; IEN leZr-‘rrv' [SEN ZEN 1 6
[mm This results in:
Jim = (61 ~ My <61 — A9} <25“)
[mu By taking the gradient of this quadratic function with respect to the real vector 6
and equating to zero, we obtain the solution:
a : {A’Afl A”,
[mm (2?)
[mm which is valid when the matrix A is well conditioned. If this is not the case, then a
regularized solution (e.g., using singular value decomposition) is sought [17]. Once the
PCT/U52012/033584
coefficients 6 are obtained, it is a simple matter to obtain [max and [max by analytically
evaluating the gradients:
36 e
= elm +.
. 2bi” + 6,, . (29)
and solving the matrix equation:
[tarmac] — uc 20; C "d ’
__ 21)] [—6] .
(30}
However, this solution may amount to a form of interpolation based on magnitude
only, which may result in unacceptably high levels of bias and variance in the estimation
of the true correlation peak, especially in the axial direction. This is due to the almost
flat nature of the surface described by q in the axial direction (axial extent of only i] lag
samples). However, q typically has a distinct peak in the l direction, and the
derivative in this direction yields a reliable estimate ofthe peak. It is known that the
analytic nature of ultrasonic echo signal allows for high subsample accuracy in axial shift
estimation by using x cross correlation without interpolation. An improved
solution may be ed ifthe lateral estimate from surface fitting solution described by
(3 O) with the axial estimate obtained from the analytic RF data.
Accounting for phase information in 2-D can be done easily by using (13) as a
constraint in ction with an appropriate cost function (e.g., using the Lagrange
multiplier method). To do this, we recognize that the polynomial fit fiinction given in
(21) is itself a quadratic cost function in lx and 1:. That is, one can rewrite (21) in the
form:
PCT/U52012/033584
title — 523:5) lz —— dag) : l’RL
l (31)-
Where dxo and dzo are the coordinates ofthe center ofthe 3 X 3 grid in the ty
ofthe true peak and l = [Ix-dxo, ] ’. The elements ofR are obtained fiom the
solution to least squares problem in (23). This can be shown by expanding the translated
vector form in (31) and comparing with the coefficients of 12x, [25 and 1x15 in (21). The
optimization problem is to find the ple shift vector 51: [5h 55] ’ (note that lmax =
[dxo, dzo] ’+[6x, 65] ’) that minimizes (31) subject to the aints:
”1‘9? :
— m ’m = 1, which implies
The first constraint isjust a normalization that is typically used in eigenvalue
problems. The second constraint restricts the solution vector to be orthogonal to the
zerophase line at the true peak (13). The elements ofm are obtained from the center
frequency values in (6) and (7).
The constraints above allow us to define a new cost function in terms of the
Lagrange multipliers, A and ,u:
J (51) = 51’1151— At51’51)+n5l’mi (‘32)
The solution to this problem can be obtained by taking the gradient ofJ with
respect to 61:
BJ i ,
' ——- = ‘3’R51 —— 2Ab] + inn I 3
. (3 g)
PCT/U52012/033584
Multiplying by m’ and g for ,u:
{1, H —~2111’R61 -- ZAm’61 (34)
H —2111’R51, (35)
where the orthogonality constraint was used to drop the second term in (34).
Substituting ,u back in (33), we obtain the eigenvalue problem:
213m -— 2Ac‘il —-— 2111’Ra1 : 0
(36').
:f» (I - 111111’) 1151 = Adlt
The solution to this eigenvalue problem is the eigenvector ated with the
maximum eigenvalue of the matrix (I vmm ’)R. The Lagrange multiplier, it, is the
eigenvalue, which appropriately scales the eigenvector to give the true lag (at the true
maximum). The projection matrix, (1 ~-mm’), serves to align the solution obtained based
on the magnitude—only method to be orthogonal to the ed slope of the zero—phase
contour. Thus the ng between the phase and magnitude characteristics for finding
the true peak of the 2~D cross correlation is te.
Various steps, routines, or processes may be implemented with the exemplary
speckle tracking methods described herein (such as those bed in Ebbini (2006)),
that further assist in ing useful image data or enhancement of image data. For
example, when performing speckle tracking of speckle regions in the region in which at
least one portion of a blood vessel is located, if the Speckle region (i.e., window or
speckle cell) being tracked is partially within the vessel wall defining the at least one
portion of the blood vessel and partially outside ofthe vessel wall (e.g., lying lly in
the blood within the vessel or lying partially outside ofthe boundaries ofthe vessel
wall), the speckle tracking s may be lt to carry out or result in data that is
inaccurate (e.g., difficult to cross correlate, etc). As such, at least in one embodiment,
once a vascular characteristic is identified or determined (e.g., the identification of one
or more boundaries (or portions thereof) of the vessel based on speckle tracking), the
vascular characteristic may be used in performing the speckle tracking method.
PCT/U52012/033584
For e, one or more vessel wall boundaries may be identified based on the
speckle ng of one or more speckle regions. Once such boundaries are identified,
they can be used in the speckle tracking process. In one or more embodiments, for
example, a characteristic of the one or more speckle regions (e.g., location, size, shape,
etc.) may be modified based on the at least one identified vascular characteristic (e.g.,
such as the identification of vessel wall boundaries). For example, the location of at
least one of the one or more speckle regions being tracked may be modified (e.g., or any
other teristic of one or more speckle regions, such as size, or shape, may be
modified) based on the one or more vessel wall boundaries identified (e.g., such that the
speckle region being tracked is entirely within or outside ofthe vessel wall). In other
words, ifthe speckle tracking s determines that a e region or window being
tracked is partially within the vessel wall defining the at least one portion of the blood
vessel and partially e of the vessel wall (e.g., lying partially in the blood within the
vessel or lying partially outside ofthe boundaries of the vessel wall), then the speckle
region location may be modified or otherwise adjusted such the speckle region is entirely
located within the vessel wall or outside of the vessel wall. Further, the size or shape
(e.g., narrowness or width or ) ofthe speckle region tracked may be modified
during the speckle tracking such that the speckle region is entirely located within the
vessel wall or outside ofthe vessel wall, or provides y estimates, e.g., of
displacement. In other words the speckle region is modified such that it falls entirely
outside the vessel wall, entirely within the vessel wall, or entirely within the blood, based
on the one or more boundaries determined for the vessel (e.g., by prior speckle ng
and generation of strain and/or shear strain image data for the region in which the at least
one p01tion of the vessel is located).
For example, generally, ng windows are designed to optimize or achieve a
tradeoff between spatial resolution (e.g., generally improved by reducing the window
size) and reducing the variance ofthe displacement estimates (e.g., generally, by
increasing the window size). For example, in one embodiment, for a uniform speckle
region, the signal—to—noise (SNR) of the echo data, together with the transducer
bandwidth, are the primary s in selecting the window size. rmore, in the
absence of severe deformation, windows are designed to be approximately square, i.e.,
approximately the same axial and lateral ions. Near the vessel wall, especially on
WO 42455 PCT/U52012/033584
the lumen side, many assumptions may be violated. High frame rate imaging (e.g., M2D
mode imaging) is provided to mitigate some ofthese effects, but there may also be a
need to account directly for deformations within the tracking window (e.g., part ofthe
window being in the vessel and part in the blood leading to deformation issues). In such
cases, one may apply adaptive window size and shape design or selection algorithms that
will produce optimal estimates (e.g., best possible displacement estimate). The 2D
phase—coupled algorithm provides feedback on the quality of the estimates (e.g., figures
ofmerit). These figures t may be used in terizing the quality ofthe
estimate obtained, for example, using different windows with the same height, but
different Width and vice versa. As such, it is possible to run these windows in parallel
and implement a voting scheme that selects the estimates with the highest figures of
merit and reject or weigh down (e.g., apply a lower weighting factor) the estimates with
lower figures of merit.
Still further, vessel wall echo reverberations may corrupt pulse—echo data received
from the blood. As such, in one or more embodiments of speckle ng of one or
more speckle regions within the blood, the speckle tracking may remove echo
components in the pulse—echo data clue to reflection at the vessel wall when performing
such speckle ng ofthe pulse-echo data fiom the one or more speckle s in the
blood (e. g., using a dereverberation filter).
In other words, as described herein, various e tracking methods (e.g., two—
ional speckle tracking methods) can be used to image tissue motion and
deformations in the vicinity ofblood vessels (e.g., for use in detecting and staging of
vascular e). However, in one or more embodiments, vessel wall echo
reverberations may overwhelm the echoes (scattering) from the blood and result in loss
offlow information in large regions within the vessel. One embodiment that may be
used to correct for such reverberations includes use ofa time-varying dereverberation
inverse filter for echo data within the vessel (e.g., echo data from the blood). The design
for such a filter may be influenced by the fact that the reverberation pattern varies
significantly with the pulsatory motion ofthe vessel wall. Minute changes in the
on/orientation ofthe vessel wall with respect to the imaging beam result in
measurable changes in the e—specular echo mixture at the vessel wall and the
observed periodicities in the reverberation pattern Within the vessel. Therefore, a time—
PCT/U52012/033584
varying inverse filter may be used to remove the reverberation components appropriately
during the heart cycle.
e tracking (e. g., two-dimensional e tracking) can be used for the
analysis oftissue motion and deformation, especially in vascular imaging applications.
In addition to the direct measurements and/or characterization ofthe vessel cs,
such speckle tracking may provide tissue cement fields and underlying anatomical
information le for important challenge areas such as computational fluid dynamics.
For example, as described herein, simultaneous estimation of tissue
motion/deformation and blood flow vector ty in a blood vessel (e.g., the human
carotid artery) using pulse—echo diagnostic ultrasound can be med (e.g., using
phase~coupled two—dimensional speckle tracking which achieves subsample
displacement estimation cy in both axial and lateral directions together with a high
frame rate (e.g., 325 frames per second) M2D g mode both lateral flow velocity
and wall motion can be estimated simultaneously thus providing pressure (through vessel
diameter) and flow (through vector velocity». Such measurements can provide the basis
for hemodynamic computations that may be used in the assessment of vessel wall
compliance, an important indicator of the health of the vessel as described herein.
r, as described herein, axial and l displacement fields are well-behaved and
allow for strain and shear strain calculations in both tissue and blood. Together with
anatomical image information, these ty/strain fields may provide input for
computational fluid dynamic models, which may allow for inverse calculations suitable
for the assessment of the health of the vasculature and surrounding tissue (e.g. detection
and staging of atherosclerosis).
One possible limitation oftwo-dimensional speckle tracking s based on
pulse—echo ultrasound is the reverberation components associated with strong specular
reflectors. Reverberation produces clutter signal components that mix with back
scattering components from regions distal to the specular reflector. This is significant in
blood vessels where the scattering from blood is typically 30 ~ 40 dB below the specular
reflection from the vessel wall. For applications where both the tissue motion and blood
velocity vectors are impmtant, however, the r due to reverberation from the region
PCT/U52012/033584
within the vessel walls should be minimized. An algorithm for dereverberation of pulse—
echo ultrasound data to restore echoes from the blood scattering region prior to two—
dimensional speckle tracking may be used to address such reverberations. Due to the
changes in the scattering characteristics ofthe vessel wall during the different phases of
the heart cycle, it is observed that the reverberation signal components are non—
nary, which indicates that a time—varying inverse filter for dereverberation may be
needed. One possible filter design approach may utilize short—range correlation for the
echo signal from the wall and the long-range ation of the echo signal from the
al wall and the vessel region. Periodicities in the correlation functions are
attributed to the vessel wall architecture and multilayer tissue ure resulting in
distinct specular components (eg. adventia).
The following provides one or more implementations of dereverberation or
examples testing the same. Such specific implementations or examples are not to be
taken as being limiting to the present disclosure.
Exemplary Dereverberation Filtering Information
Data Acquisition for the example Dereverberation Filtering
A Sonix RP (Ultrasonix, Canada) ultrasound scanner loaded with a program used
for MZD pulse—echo data collection. Collected data is then lined to a controller
PC through Gigabit Ethernet for real-time data processing. The data sing
computer can easily handle the intensive computations ed by high resolution (both
spatial and temporal) speckle ng and separable 2D post filtering by utilizing a many
core GPU (nVlDIA, Santa Clara, CA) A linear array probe (LAl4-5/3 8) was used to
acquire all data of this example. The center cy of the transmit pulse on the probe
was 7.5 MHZ.
Received Signal Model
A received signal model for echo beamformed ultrasound data obtained fiom
a typical scanner and typical vascular probe such as those bed above is provided.
The echo data forming one image line is given by
PCT/U52012/033584
x,.(r,l) 2237431) +x,:(r,l) (l)
where xcfi‘; 1) represents the coherent echo ent from depth 2 =c/t in image
line I and x,{t; Z) is the incoherent echo component fi'om the same location. At the vessel
wall, the coherent ent is largely due to specular reflection from the multi—layered
vessel and supporting structure. For simplicity, assume a single layer in a homogeneous
medium and a narrowband model:
27 m 22 21%];
KAI-J) : Rer (I ”" “39) (2). .
‘l‘ X 06k}? (I " "B ‘“
' C C
k=l u)
r ’ 6 t'
__ T ( )is)
where [3 (t) ‘“‘ («Hawk the analytic transmitted ultrasound pulse, RN
is the reflection coefficient, and dw is the vessel wall thickness. In (2), Rm, ents the
tissue-wall reflection coefficient and ak is a fimction of the wall—tissue reflection and
ission coefficients. The reflection coefficients are typically small (e.g. < 10%)
and the series in (2) is practically 2 to 4 terms for each layer. Unfortunately, the
reverberation terms interfere with the echo components from the blood in the .
Despite their rapid decay, their ude remains high enough to mask the echoes fiom
the blood in a region that extends several millimeters inside the vessel. A
dereverberation filter can be used to unmask the echoes from the blood and allow the
mensional speckle tracking to estimate vector velocity inside the vessel.
Inverse Filter Design for Echo Dereverberation
The correlation function of the coherent echo component exhibits secondary peaks
at rk =2kdw/c. The amplitude ofthese peaks diminishes exponentially with k (due to
multiple reflection within the wall). These secondary peaks can be estimated from the
autocorrelation function ofthe echo data after baseband conversion. Results from actual
vascular imaging experiments suggest that a Gaussian mixture model (GMM) may be
most appropriate for ng the probability density function (pdt) ofthe clean echo
data. The GMM is also motivated by a number of eses on the scattering by blood
(e.g. due to flow or red blood cell aggregation). An infinite impulse response (HR)
model is assumed for the dereverberation inverse filter
PCT/U52012/033584
fin] :: fin] — Z 611;)?[11 - k] (3)
[(521
The coefficients, {Gk }k=l can be ed by maximizing the log—likelihood with
respect to the GMMs in the flow channel:
[2323 where Ng is the number of Gaussian densities in the GMIVI (each represented by
{wg/Ji, 01}) and M, is the length of output test sequence. The parameters of the HR inverse
filter can be obtained by maximizing 3’ in (4) by partial tives with respect to
{aklii—Til,
8$__1 "0+er Ng ‘3 (33[n] -,LL;)3*[12——k]
Z“ M- ()5
861k :N) (52
{233] 17—-2110 i: i
where é-‘Eaand ”5"»: are the ith term inside the inner summation in (4) and the inner
summation, respectively. The parameters ofthe filter can be obtained iteratively through
(33’
(1/;[171 + l] = (1k [/72] + 5W (6)
where m is the ion index and d is chosen sufficiently small to allow for fine
convergence (at the expense of convergence speed). In at least one embodiment, (5) can
be simplified ifthe GMIM is dominated by one distribution, which is often the case. At
any rate, an empirical values of 5 =0:01 result in convergence within 10 iterations or
less.
order Selection: The parameter N in (3) can be determined from the
identification of secondary peaks in the autocorrelation fimction of the complex envelope
PCT/U52012/033584
ofthe echo data fiom the proximal vessel wall and from the vessel including the
proximal wall. Periodicities in these correlation functions are fiable with the wall
(and supporting-tissue) architecture, which is primarily responsible for reverberation
within the . For the carotid artery of an typical human subject, the order varies
depending on the phase of the cardiac cycle with a range of 20 — 45 (lower orders when
the vessel wall is maximally stretched). A maximum value, Nmax on the model order
could be set from the observation of the icities throughout the heart cycle.
Reverberation-free Training Data
ing reverberation—free echo data can be accomplished by tilting the imaging
transducer to avoid specular ions from the vessel wall (after identifying the vessel
wall). In practice, a very small tilt is sufficient to significantly remove the specular echo
and maintain a good view ofthe vessel. Color flow or power Doppler mode can be used
to define the flow region for extracting the training echo data. Once this is achieved, the
imaging transducer is returned to a position where the vessel ries can be best
defined from specular reflections. It is also possible to get reverberation-free data fiom
corrupted views by carefully selecting s where the reverberation components are
not present.
For example, a blood vessel with 6—mm diameter may provide 2 mm region of
reverberation-free echo data at its distal end. One can use the latter approach to identify
the GMIVI during a typical heart cycle. Based on actual echo data from a human subject,
the value chg in (4) is typically 3 to 4, all with zero mean.
arying Filter Design Algorithm
Based on the above derivation and facts about the data acquisition model for
beamformed echo data from typical vascular imaging ultrasound, the following filter
design steps are provided. For image line 1 and image frame p,
Step 0 Detect the proximal vessel wall from complex envelope data.
~58—
PCT/U52012/033584
Step 1 Determine the HR model order, N, from the short range and long—range
correlation functions.
Step 2 Determine the GlVEM parameters from the reverberation free segment of the
vessel echo data.
Step 3 Determine the filter coefficients using the m likelihood algorithm
(Equations 4 — 6).
Step 4 Apply the HR filter to vessel data with appropriate initial conditions to avoid
breaks in the echo data.
Step 5 Compute long—range correlation function on y[n]. If reverberation still
detectable, While N < Nmax GoTo Step 3. Otherwise Stop.
s and Discussion regarding Example:
Data Collection — The Sonix RP was used to collect MZD mode data from imaging
the right carotid artery of a y volunteer. Real-time beamformed RF data was
collected at a frame rate of 325 fps and processed off—line to produce images similar to
those shown in s 16A—16B, which shows lateral (Figure 16A) and axial
cements (Figure 168) ofthe carotid artery coded (in color or gray scale) and
overlaid on the B-mode gray scale . The displacement fields were estimated
using the phase coupled two—dimensional speckle tracking algorithm described in Ebbini
2006.
Approximately 1.9 seconds (642 frames) of data was acquired capturing more than
three heart cycles to allow for modeling the dynamics of echoes and reverberation fi‘om
the vessel, primarily due to the al wall. Spatio—temporal maps ofthe echoes from
the vessel (proximal wall through the vessel, but excluding the distal wall) are shown in
Figure 17A. The image shows the envelope of the RF data from one image line
(approximately at the center ofthe images). This is ed to as M—mode ultrasound
and it allows for the analysis of wall motion in cardiac and vascular imaging application.
_59_
PCT/U52012/033584
Figure 17B shows an M—mode image ofthe echoes from the proximal wall only
during the acquisition period. The image illustrates the dynamics of the wall echoes
during the heart cycle. For example, for the first few lines (0 < t < 0: ls), the wall
represents a purely specular reflector. On the other hand, the wall echo appears less
zed when the wall undergoes ion due to pressure changes in the vessel.
Examining the envelope in the vessel shown in Figure 17A, one can see a strong
reverberation pattern down to about 4 mm into the vessel. This pattern masks any
scattering from the blood and makes it difficult, ifnot impossible, to estimate the flow
velocity vectors in a large region within the vessel.
Figures ISA-18B show spatio—temporal maps ofnormalized correlation fimction of
the complex envelope from the vessel including the proximal wall (Figure 18A — a long
range correlation) and proximal wall only (Figures 18B —— a short range correlation)
corresponding to the M—mode images shown in Figures l7A-l7B. One can see the
strong secondary peaks at z 3: 0:8 mm when the vessel wall is not stretched and s
as a specular reflector. On the other hand, this peak is diminished and the main lobe of
the correlation function is ned when the vessel wall is stretched. This result
demonstrates that a time—varying dereverberation filter will be ial.
[254} Figures l9A—l9D illustrate the performance ofthe dereverberation filters obtained
through the proposed maximum hood algorithm. Using short—range and long—range
correlation data, the filter order was determined to be 21 for two frames (Frame 1 at t =
0.003 s and Frame 100 at 1‘: 0.31 sec). The GMM models were estimated from the
vessel data near the distal wall using Ng = 3. Ny = 50 was used in both cases and 5 =
0:005. Convergence was achieved in 7 and 9 ions for Frame 1 and Frame 100 data,
respectively. The magnitude response of both filters demonstrate e filtering and
dereverberation characteristics; signal bandwidth 2 — 6 MHZ is inverted and ripple
throughout. Figures 19A-19D represent the dereverberation filters and vessel data with
and without filtering for Filter Frame 1 (Figures l9A-19B) and Filter Frame 100 (Figures
D) (the filtered signals generally being closer to 0 line axis than the al).
Results from vascular imaging experiment from a healthy eer demonstrate
the feasibility of dereverberation of echo data fiom blood vessels using time—varying
inverse rberation filters to account for the time—varying nature ofthe reverberation
~60—
2012/033584
components during the heart cycle. Such filtering may for more accurate vector velocity
estimation in the vessel using speckle ng (e.g., two—dimensional e tracking)
methods. The exemplary algorithm is robust and computationally efficient and requires
minimal training making it well-suited for real—time ultrasound imaging applications.
The following provides one or more implementations ofvascular imaging and
characterization ofvessel wall dynamics or examples testing the same, such as generally
described herein. Such specific implementations or examples are not to be taken as
being ng to the present disclosure.
Generally, a method for simultaneous imaging oftissue motion and flow with
subsample accuracy in both axial and lateral directions is illustrated. The method
utilizes a phase-coupled 2D e tracking approach, which employs the true 2D
complex cross correlation to find sub—pixel displacements in both axial and l
directions. The imaging sequence on a Sonix RP scanner has been d to allow
high frame rate 2D data collection in a limited field ofview covering the region of
interest (MZD—mode). er with the robust 2D e tracking method, M2D
imaging allows for capturing the full dynamics of the flow and wall/tissue motion, even
when the flow is primarily in the lateral direction (with respect to the g beam).
The fine vector displacement tes in both axial and lateral directions are shown to
allow for smooth and contiguous strain and shear strain calculations with minimal
filtering. The quality ofthe displacement and strain fields is demonstrated by
experimental results from a flow phantom (ATS Model 524) and in viva images of the
carotid artery in a healthy volunteer. The results demonstrate simultaneous imaging of
the vector flow field and the wall/tissue motion and the corresponding strains at high
spatial and temporal sampling. This may e an essential tool in ng the fluid—
solid interactions between the blood and blood vessel.
Materials andMethodsfor an Exemplary Imaging Method
Coupled 2D Speckle Tracking — The phase—coupled 2D speckle tracking
algorithm used is described in Ebbini 2006 and also at least partially described herein.
The speckle tracking method is based on the gradients of the magnitude and phase of2D
complex correlation in a search region. This approach couples the phase and magnitude
PCT/U52012/033584
gradients near the correlation peak to determine its coordinates with subsample accuracy
in both axial and lateral directions. This is achieved with a m level of lateral
interpolation determined from the angles between the magnitude and phase gradient
vectors on the d (laterally interpolated) 2D cross—correlation grid. One result
behind this algorithm is that the magnitude gradient vectors” final approach to the true
peak is orthogonal to the zero—phase contour. This leads to a 2D robust projection on the
hase contour that s in subsample accuracy at interpolation levels well below
those needed using previously proposed methods. It is shown that estimated 2D vector
displacement fields obtained using the phase—coupled technique display a full range of
values covering the c range without evidence of quantization. In comparison, a
previously published method using 1D phase—projection after lateral interpolation
produces severely quantized lateral displacement fields (at the same levels of
interpolation as the 2D, phase—coupled method).
Data Acquisition - A Sonix RP (Ultrasonix, Canada) ultrasound scanner loaded
with a program used for high frame—rate MZD pulse-echo data collection is used.
Collected data is then streamlined to a controller PC through t Ethernet for real—
time data processing. The data processing computer can easily handle the ive
computations required by high resolution (both spatial and al) e tracking
and separable 2D post filtering by utilizing a many core GPU (nVlDIA, Santa Clara,
CA). A linear array probe (LA14—5/3 8) was used to acquire all data shown in this paper.
The center frequency of the transmit pulse on the probe was 7.5 MHZ.
Experiments using the ATS Model 524 flow phantom and a Cole—Farmer
MasterFlex roller pump were conducted to illustrate the displacement tracking in axial
and lateral directions. M2D data was collected using the Sonix RP scanner at a frame
rate of 111 fps. Images of a 4—mm flow channel in the ATS phantom were collected
under controlled fluid flow with an appropriate speed setting of the MasterFlex pump to
mimic typical blood flow rates (6.g. 336 ml/min) in carotid arteries. Cellulose
pheres were diluted in water to produce linear ring fiom the flow channel
during data collection (pure water was also imaged as a l to determine the channel
boundaries as a ground truth).
~62—
PCT/U52012/033584
Strain ation — Strain and shear strain calculations were performed using
MATLAB’S nt command on the axial and lateral displacement fields obtained
using the 2D speckle ng algorithm. The strain and shear strain computations are
followed by a simple Gaussian lowpass filter with size of 3 3 and standard deviation of
l, i.e. minimal post filtering of the strain and shear strain fields.
s and Discussion Regarding the Exemplary Imaging Method
Experimental Phantom Result
The 4-mm flow channel was imaged using the LAl4—5 probe with the channel axis
perpendicular to the beam axis, i.e. lateral flow. Typical examples of the resulting strain
and shear strain fields are shown in Figures 8A—8B and Figures 9A—9B. Figures 8A~8B
Show axial strain and axial shear strain ofthe 4mm flow channel longitudinal walls,
respectively. Figures 9A-9B show lateral strain and lateral shear strain of the 4—mm flow
channel longitudinal walls, respectively. One can see the smoothness ofthe strain fields
which demonstrates the well—behaved nature ofthe displacement fields. At the same
time, one can appreciate the clear ation between the channel and the surrounding
tissue-mimicking material.
The dynamics of the estimated vector flow field are rated by the result in
Figure l0 which shows a plot of the periodic channel diameter (dashed lines) (obtained
from the axial component at the channel walls computed fiom the tracked channel wall
displacement) and the corresponding average lateral flow velocity in the channel (solid
lines) for several cycles ofpump operation (i.e., within the 4 mm flow channel in the
ATS phantom). The result shows clearly the quasi—periodic nature of the observed flow
ty and the phase relationship n the diameter ure in the channel) and
flow. Note that the small negative ccmponent in the flow velocity occurs right after the
diameter reaches its maximum value (i.e. minimum re in the channel). This “back
up” of the fluid in the channel was easily observed in B-Inode movies, but the wall
motion was much more subtle (< 150mm) and was only seen in the axial displacement
field.
WO 42455 PCT/U52012/033584
The dynamic behavior of the lateral flow along the axis ofthe imaging beam (at a
lateral distance of —3 .2 mm) is illustrated by Figure ll. One can see the , well—
behaved nature ofthe lateral displacement fields consistent with the quasi-periodic
pattern shown in Figure 10. It is noted that the results shown in Figure ll are minimally
processed, i.e., the continuity and the high SNR of the vector displacement estimation in
the fluid and the surrounding tissue is a direct consequence ofthe proper application of
the phase—coupled 2D speckle tracking method.
In Vivo Experiment
A t ofthe d artery of a healthy volunteer was imaged using the LAM—
probe at 1 ll fps. As in the phantom case, the axial and lateral displacement fields
were contiguous throughout the region of interest and allowed for the ation ofthe
strain and shear strain fields shown in Figures 12A—12B and Figures l3A-lBB. Figures
12A~12B Show axial strain and axial shear strain ofthe carotid artery longitudinal vessel
walls, respectively. Figures l3A—13B show l strain and lateral shear strain of the
carotid artery longitudinal vessel walls, respectively. One can see the clear demarcation
between the vessel and the wall/perivascular tissue in the axial strain and lateral shear
strain images. Also, the pulsation effect can be appreciated from the axial shear strain
and lateral strain images. These results demonstrate reliable tion ofthe vector
motion fields (axial and lateral) and their utility in ing realistic strain and shear
strain fields.
Finally, we show a cross sectional View ofthe strain fields around the carotid artery
of a y volunteer. The strains and shear strains in both axial and lateral directions
are shown in Figures l4A~l4B and s ISA-15B, respectively. Figures l4A—l4B
show axial strain and axial shear strain ofthe carotid artery cross-sectional vessel walls,
respectively. Figures ISA—15B show lateral strain and lateral shear strain ofthe carotid
artery sectional vessel walls, respectively. Examining Figures 14A-14B one can
observe that the motion in the axial direction produced a strain in the axial direction at
the wall (Figure 14A) and a shear component to the lateral direction (Figure 14B). The
direction ofthe strains in this case depicts an expanding vessel. Similarly, the motion in
the lateral direction produced a strain in the lateral direction (Figure 15A) and a shear
component to the axial direction as in (Figure 15B). Movies of the strain and shear
PCT/U52012/033584
strain fields have showed the dynamics of wall movement clearly (such not table
in this application). In addition to the wall dynamics, the strain images provide a tool for
identifying the boundaries of the vessel in both axial and lateral directions. The latter is
generally difficult to determine from B-mode images.
As a result of the example, a method for imaging the cement and strain fields
in the vicinity of flow channels has been demonstrated experimentally in a flow phantom
and in viva imaging ofthe carotid artery ofhealthy volunteer. The results show that, at
sufficiently high frame rates, speckle tracking methods produce ehaved
displacement estimates of both the tissue motion and flow in the channel. These
displacement fields are well suited for strain and shear strain calculations with minimum
filtering. Further, it has been demonstrated that time rms offlow velocity and
pressure to follow the periodic motion ofthe roller pump in the phantom experiments.
Furthermore, the axial wall displacements (indicative of pressure) and average lateral
flow velocity in the channel have a clear phase relationship. This indicates that the
method used may be useful in obtaining the full dynamic motion fields suitable for use in
solid-fluid interface ng of vascular mechanics.
All patents, patent documents, and references cited herein are orated in their
entirety as if each were incorporated separately. This disclosure has been provided with
reference to illustrative embodiments and is not meant to be construed in a limiting
sense. As described previously, one skilled in the art will recognize that other various
rative applications may use the techniques as described herein to take advantage of
the beneficial characteristics ofthe apparatus and methods described . Various
modifications of the illustrative embodiments, as well as onal embodiments ofthe
disclosure, will be apparent upon reference to this description.
—65-
Claims (35)
1. An g method comprising: providing ultrasound pulse-echo data of a region in which at least one portion of a blood vessel is located, wherein the pulse-echo data comprises pulse-echo data at a frame rate such that measured cement of the vessel wall defining the at least one portion of the blood vessel and measured average blood flow through the at least one portion of the blood vessel have a quasi-periodic profile over time to allow motion tracking of both the vessel wall and the blood flow simultaneously; generating strain and shear strain image data for the region in which the at least one n of the vessel is located using speckle tracking, wherein the speckle tracking comprises using multi-dimensional correlation of pulse-echo data of one or more speckle regions undergoing deformation in the region in which the at least one portion of a blood vessel is located, n the dimensional correlation comprises determining a crosscorrelation peak for the sampled pulse-echo data based on phase and magnitude nts of the cross-correlated pulse-echo data; and identifying at least one vascular characteristic of the region in which at least one portion of a blood vessel is located based on the strain and shear strain image data, wherein the at least one vascular characteristic comprises at least one of a flow characteristic associated with flow through the blood vessel, a structural characteristic associated with the blood vessel, and a hemodynamic characteristic associated with the blood vessel.
2. The method of claim 1, wherein identifying at least one vascular characteristic comprises identifying one or more vessel wall boundaries.
3. The method of claim 1 or claim 2, wherein the speckle ng further comprises ing a characteristic of at least one of the one or more speckle s being d based on the one or more vessel wall boundaries identified such that the at least one speckle region is entirely within or outside of the vessel wall.
4. The method of any of claims 1 -3, wherein identifying one or more vessel wall boundaries comprises identifying vessel wall boundaries around the entire blood vessel.
5. The method of any of claims 1-4, wherein identifying at least one vascular characteristic ses measuring tissue property within the one or more vessel wall ries.
6. The method of any of claims 1-5, wherein identifying at least one vascular characteristic comprises identifying one or more portions of a plaque architecture adjacent the one or more vessel wall boundaries.
7. The method of any of claims 1-6, n identifying at least one vascular characteristic comprises calculating one or more hemodynamic measurements based on both the motion tracking motion of the vessel wall and the blood flow simultaneously.
8. The method of any of claims 1-7, wherein using multi-dimensional correlation of sampled pulse-echo data of one or more speckle regions comprises using mensional correlation of sampled pulse-echo data of one or more speckle s.
9. The method of any one of claims 1-8, wherein ining the cross-correlation peak ses: coarsely searching the magnitude of the sampled pulse-echo data in a lateral and axial direction to locate a vicinity of the cross-correlation peak within the cross-correlated sampled pulse-echo data; determining, within the vicinity of the cross-correlation peak, at least two opposing gradient vectors in proximity to the cross-correlation peak; determining, within the vicinity of the cross-correlation peak, a hase line of the cross-correlated sampled pulse-echo data; and using the at least two opposing gradient vectors in proximity to the cross-correlation peak and the zero-phase line to estimate the cross-correlation peak.
10. The method of any of claims 1-9, wherein the method further comprises determining the usage of ultrasonic energy based on the identification of the at least one vascular characteristic of the region in which at least one portion of a blood vessel is located.
11. The method of claim 10 , wherein the method further comprises providing at least one transducer configured to it and e ultrasonic energy, wherein the at least one transducer is used to obtain the pulse-echo data and to generate ultrasonic energy.
12. The method of any of claims 1-11, wherein generating strain and shear strain image data for the region in which the at least one portion of the vessel is located using ensional e tracking comprises generating at least one of axial strain and axial shear strain image data and/or lateral strain and lateral shear strain image data.
13 The method of any of claims 1-12, wherein providing ultrasound pulse-echo data of a region in which at least one portion of a blood vessel is located comprises using coded tion.
14. The method of any of claims 1-13, wherein the method further comprises applying a dereverberation filter to the pulse-echo data from one or more speckle regions in the blood to remove echo components in the pulse-echo data due to tion at the vessel wall when performing speckle tracking of the pulse-echo data from the one or more speckle regions in the blood.
15. A system for vascular imaging, comprising: one or more ultrasound transducers, wherein the one or more transducers are configured to deliver ultrasound energy to a vascular region resulting in pulse-echo data rom; and means for controlling the capture of pulse-echo data at a frame rate such that ed displacement of a vessel wall defining at least one portion of a blood vessel in the vascular region and measured average blood flow through the at least one portion of the blood vessel have a quasi-periodic profile over time to allow motion tracking of both the vessel wall and the blood flow simultaneously; means for generating strain and shear strain image data for the region in which the at least one portion of the vessel is located using speckle tracking, wherein the speckle tracking comprises using dimensional correlation of pulse-echo data of one or more speckle regions undergoing ation in the region in which the at least one portion of a blood vessel is located, wherein the multi-dimensional correlation comprises determining a cross- correlation peak for the sampled pulse-echo data based on phase and magnitude gradients of the cross-correlated pulse-echo data; and means for identifying at least one vascular characteristic of the vascular region in which at least one portion of a blood vessel is located based on the strain and shear strain image data, wherein the at least one vascular characteristic comprises at least one of a flow characteristic associated with flow through the blood vessel, a structural characteristic associated with the blood vessel, and a hemodynamic characteristic associated with the blood vessel.
16. A system for vascular imaging ing to claim 15, comprising: one or more ultrasound transducers, wherein the one or more transducers are configured to deliver ultrasound energy to a vascular region resulting in pulse-echo data therefrom; and processing apparatus configured to: control the capture of pulse-echo data at a frame rate such that measured displacement of a vessel wall defining at least one portion of a blood vessel in the vascular region and measured average blood flow through the at least one portion of the blood vessel have a quasi-periodic profile over time to allow motion ng of both the vessel wall and the blood flow simultaneously; generate strain and shear strain image data for the region in which the at least one portion of the vessel is located using speckle tracking, wherein the speckle tracking comprises using multi-dimensional correlation of pulse-echo data of one or more speckle regions oing ation in the region in which the at least one portion of a blood vessel is located, wherein the multi-dimensional correlation comprises determining a crosscorrelation peak for the sampled pulse-echo data based on phase and magnitude gradients of the cross-correlated pulse-echo data; and identify at least one vascular characteristic of the vascular region in which at least one portion of a blood vessel is located based on the strain and shear strain image data, n the at least one vascular characteristic ses at least one of a flow characteristic associated with flow through the blood vessel, a ural characteristic associated with the blood , and a hemodynamic characteristic associated with the blood vessel.
17. A system for vascular imaging ing to claim 16, comprising: one or more ultrasound transducers, wherein the one or more transducers are configured to deliver ultrasound energy to a vascular region resulting in pulse-echo data rom; and sing apparatus configured to: control the capture of pulse-echo data of the vascular region in which at least one portion of a blood vessel is located; use speckle ng of one or more speckle regions of the ar region in which at least one portion of the blood vessel is located to track motion of both the vessel wall defining the at least one portion of the blood vessel and the blood flow through the at least one portion of the blood vessel, wherein the pulse-echo data is captured at a frame rate such that displacement of the vessel wall defining the at least one portion of the blood vessel and blood flow through the at least one portion of the blood vessel are measurable aneously within a same periodic cycle corresponding to a cardiac pulse cycle; and identify at least one vascular characteristic of the vascular region in which the at least one portion of the blood vessel is located based on the simultaneously measured displacement of the vessel wall and average blood flow.
18. The system of claim 17 , wherein the processing apparatus is further operable to generate strain and shear strain image data for the region in which the at least one n of the vessel is located using the speckle tracking, wherein the speckle tracking comprises using multi-dimensional correlation of sampled pulse-echo data of the one or more speckle regions undergoing deformation in the region in which the at least one portion of a blood vessel is located, wherein the multi-dimensional correlation ses determining a cross-correlation peak for the sampled pulse-echo data based on phase and magnitude gradients of the orrelated sampled pulse-echo data.
19. The system of any of claims 16 to 18, wherein the processing apparatus is operable to identify at least one ar characteristic comprises identifying one or more vessel wall boundaries.
20. The system of claim 19, n the processing apparatus is operable, when using the speckle tracking, to modify a characteristic of at least one of the one or more speckle regions being tracked based on the one or more vessel wall boundaries identified such that the at least one speckle region is entirely within or outside of the vessel wall.
21. The system of any of claims 19-20, wherein the processing apparatus is operable to identify vessel wall boundaries around the entire blood vessel.
22. The system of any of claims 19-21, wherein the processing apparatus is operable to measure tissue property within the one or more vessel wall ries.
23. The system of any of claims 19-22, wherein the processing apparatus is le to identify one or more portions of a plaque architecture adjacent the one or more vessel wall boundaries.
24. The system of any of claims 19-23, wherein the processing apparatus is operable to calculate one or more hemodynamic measurements based on both the motion tracking motion of the vessel wall and the blood flow simultaneously.
25. The system of any of claims 19-24, wherein the processing apparatus is operable to use mensional correlation of sampled pulse-echo data of one or more speckle regions.
26. The system of any of claims 19-25, n the processing apparatus is operable to control the determination of the cross-correlation peak by at least: coarsely searching the ude of the sampled pulse-echo data in a lateral and axial direction to locate a vicinity of the cross-correlation peak within the cross-correlated sampled pulse-echo data; determining, within the vicinity of the cross-correlation peak, at least two opposing gradient vectors in proximity to the cross-correlation peak; determining, within the vicinity of the cross-correlation peak, a hase line of the correlated sampled pulse-echo data; and using the at least two opposing gradient vectors in ity to the cross-correlation peak and the hase line to estimate the cross-correlation peak.
27. The system of any of claims 19-26, wherein system further includes a therapy system to deliver therapy to a patient based on the identification of the at least one vascular characteristic of the region in which at least one portion of a blood vessel is located.
28. The system of claim 27, wherein the therapy system comprises a system operable to use ultrasonic energy to deliver therapy based on the identification of the at least one vascular characteristic of the region in which at least one portion of a blood vessel is located.
29. The system of any of claims 27-28, wherein the therapy apparatus comprises at least one transducer configured to transmit and receive ultrasonic energy, wherein the at least one transducer is operable to provide ultrasonic energy to deliver therapy based on the identification of the at least one ar characteristic of the region in which at least one portion of a blood vessel is d and the at least one transducer is operable for use in obtaining the pulse-echo data to generate image data.
30. The system of any of claims 16-29, wherein the sing apparatus is operable to generate strain and shear strain image data for the region in which the at least one portion of the vessel is located using two-dimensional speckle tracking, wherein using two-dimensional speckle tracking comprises generating at least one of axial strain and axial shear strain image data and/or lateral strain and l shear strain image data.
31. The system of any of claims 16-30, wherein the sing apparatus is operable to control ing ultrasound pulse-echo data of a region in which at least one portion of a blood vessel is located using coded excitation.
32. The system of any of claims 16-30, wherein the processing apparatus is le to apply a dereverberation filter to the pulse-echo data from one or more speckle regions in the blood to remove echo components in the pulse-echo data due to reflection at the vessel wall when performing speckle tracking of the echo data from the one or more speckle regions in the blood.
33. The system of claim 15, wherein the system further includes therapy means for delivering y to a patient based on the identification of the at least one vascular characteristic of the region in which at least one portion of a blood vessel is located.
34. The system of claim 33, wherein the therapy means comprises a system operable to use ultrasonic energy to deliver y based on the identification of the at least one vascular characteristic of the region in which at least one portion of a blood vessel is located.
35. The system of claim 15, claim 33 or claim 34, wherein the therapy means comprises at least one transducer configured to transmit and receive onic energy, wherein the at least one transducer is operable to provide ultrasonic energy to r therapy based on the identification of the at least one vascular characteristic of the region in which at least one portion of a blood vessel is located and the at least one transducer is operable for use in obtaining the pulse-echo data to generate image data. PCT/U
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161475550P | 2011-04-14 | 2011-04-14 | |
US61/475,550 | 2011-04-14 | ||
PCT/US2012/033584 WO2012142455A2 (en) | 2011-04-14 | 2012-04-13 | Vascular characterization using ultrasound imaging |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ615910A NZ615910A (en) | 2015-11-27 |
NZ615910B2 true NZ615910B2 (en) | 2016-03-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11547384B2 (en) | Vascular characterization using ultrasound imaging | |
KR101651830B1 (en) | Feedback in medical ultrasound imaging for high intensity focused ultrasound | |
JP7132925B2 (en) | Ultrasound imaging system using neural networks for deriving imaging data and tissue information | |
CN105793729B (en) | It is formed and/or is rebuild using the ultrasonoscopy of multi-frequency waveform | |
EP2237725B1 (en) | Therapy assessment with ultrasonic contrast agents | |
KR20180013956A (en) | Method, system and computer program product for single tracking position shear wave elastic imaging | |
EP3082616A1 (en) | Computed ultrasound tomography in echo mode (cute) for imaging speed of sound using pulse-echo sonography | |
JP2021522011A (en) | Systems and methods for ultrasound screening | |
JP2003210460A (en) | Shearing modulus measuring device and therapeutic device | |
EP3914161B1 (en) | Methods and systems for investigating blood vessel characteristics | |
JP7507765B2 (en) | Method and system for monitoring cardiac function - Patents.com | |
CN112773403A (en) | Ultrasonic imaging method and system | |
NZ615910B2 (en) | Vascular characterization using ultrasound imaging | |
Zhou et al. | Transcranial ultrafast ultrasound Doppler imaging: A phantom study | |
Dickie et al. | A flexible research interface for collecting clinical ultrasound images | |
Healthcare | UITC ABSTRACTS 2017 | |
Pelissiera et al. | A Flexible Research Interface for Collecting Clinical Ultrasound | |
Ahmed et al. | Strain Estimation Techniques Using MATLAB Toolbox for Tissue Elasticity Imaging | |
Park | Integrated system for ultrasonic, elasticity and photoacoustic imaging |